{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T18:29:25Z","timestamp":1785522565563,"version":"3.56.0"},"reference-count":228,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s12325-026-03620-5","type":"journal-article","created":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T09:29:05Z","timestamp":1779182945000},"page":"3247-3280","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["An Update and Overview of the Ocular and Extraocular Microbiome and Its Impact on Ophthalmic Care"],"prefix":"10.1007","volume":"43","author":[{"given":"Konstantinos","family":"Benekos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Katsanos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiotis","family":"Laspas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios D.","family":"Panos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iordanis","family":"Vagiakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fotios S.","family":"Fousekis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Luca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beryl","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charilaos","family":"Kostoulas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Georgiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos H.","family":"Katsanos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitra","family":"Skondra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasios G.","family":"Konstas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,19]]},"reference":[{"issue":"Suppl 1(Suppl 1","key":"3620_CR1","doi-asserted-by":"publisher","first-page":"S38","DOI":"10.1111\/j.1753-4887.2012.00493.x","volume":"70","author":"LK Ursell","year":"2012","unstructured":"Ursell LK, Metcalf JL, Parfrey LW, Knight R. Defining the human microbiome. Nutr Rev. 2012;70(Suppl 1(Suppl 1)):S38-44. https:\/\/doi.org\/10.1111\/j.1753-4887.2012.00493.x.","journal-title":"Nutr Rev"},{"issue":"12","key":"3620_CR2","doi-asserted-by":"publisher","first-page":"2699","DOI":"10.4103\/1673-5374.373687","volume":"18","author":"W Luo","year":"2023","unstructured":"Luo W, Skondra D. Implication of gut microbiome in age-related macular degeneration. Neural Regen Res. 2023;18(12):2699\u2013700. https:\/\/doi.org\/10.4103\/1673-5374.373687.","journal-title":"Neural Regen Res"},{"key":"3620_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10102072","author":"P Lin","year":"2021","unstructured":"Lin P, McClintic SM, Nadeem U, Skondra D. A review of the role of the intestinal microbiota in age-related macular degeneration. J Clin Med. 2021. https:\/\/doi.org\/10.3390\/jcm10102072.","journal-title":"J Clin Med"},{"issue":"3","key":"3620_CR4","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1097\/ICU.0000000000000836","volume":"33","author":"U Nadeem","year":"2022","unstructured":"Nadeem U, Boachie-Mensah M, Zhang J, Skondra D. Gut microbiome and retinal diseases: an updated review. Curr Opin Ophthalmol. 2022;33(3):195\u2013201. https:\/\/doi.org\/10.1097\/ICU.0000000000000836.","journal-title":"Curr Opin Ophthalmol"},{"issue":"6","key":"3620_CR5","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1177\/1535370218813616","volume":"244","author":"AD Baim","year":"2019","unstructured":"Baim AD, Movahedan A, Farooq AV, Skondra D. The microbiome and ophthalmic disease. Exp Biol Med (Maywood). 2019;244(6):419\u201329. https:\/\/doi.org\/10.1177\/1535370218813616.","journal-title":"Exp Biol Med (Maywood)"},{"issue":"1","key":"3620_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41421-021-00245-6","volume":"7","author":"Y Deng","year":"2021","unstructured":"Deng Y, Ge X, Li Y, Zou B, Wen X, Chen W, et al. Identification of an intraocular microbiota. Cell Discov. 2021;7(1):13. https:\/\/doi.org\/10.1038\/s41421-021-00245-6.","journal-title":"Cell Discov"},{"issue":"3","key":"3620_CR7","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.jtos.2016.04.004","volume":"14","author":"A Kugadas","year":"2016","unstructured":"Kugadas A, Gadjeva M. Impact of microbiome on ocular health. Ocul Surf. 2016;14(3):342\u20139. https:\/\/doi.org\/10.1016\/j.jtos.2016.04.004.","journal-title":"Ocul Surf"},{"issue":"29","key":"3620_CR8","doi-asserted-by":"publisher","first-page":"8787","DOI":"10.3748\/wjg.v21.i29.8787","volume":"21","author":"SM Jandhyala","year":"2015","unstructured":"Jandhyala SM, Talukdar R, Subramanyam C, Vuyyuru H, Sasikala M, Nageshwar Reddy D. Role of the normal gut microbiota. World J Gastroenterol. 2015;21(29):8787\u2013803. https:\/\/doi.org\/10.3748\/wjg.v21.i29.8787.","journal-title":"World J Gastroenterol"},{"issue":"6","key":"3620_CR9","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1097\/APO.0000000000000330","volume":"9","author":"JAP Gomes","year":"2020","unstructured":"Gomes JAP, Frizon L, Demeda VF. Ocular surface microbiome in health and disease. Asia Pac J Ophthalmol. 2020;9(6):505\u201311. https:\/\/doi.org\/10.1097\/APO.0000000000000330.","journal-title":"Asia Pac J Ophthalmol"},{"issue":"3","key":"3620_CR10","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1086\/350265","volume":"58","author":"JL Larson","year":"1967","unstructured":"Larson JL. Linnaeus and the natural method. Isis. 1967;58(3):304\u201320. https:\/\/doi.org\/10.1086\/350265.","journal-title":"Isis"},{"issue":"7","key":"3620_CR11","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1038\/s41396-021-00941-x","volume":"15","author":"P Hugenholtz","year":"2021","unstructured":"Hugenholtz P, Chuvochina M, Oren A, Parks DH, Soo RM. Prokaryotic taxonomy and nomenclature in the age of big sequence data. ISME J. 2021;15(7):1879\u201392. https:\/\/doi.org\/10.1038\/s41396-021-00941-x.","journal-title":"ISME J"},{"issue":"6","key":"3620_CR12","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.survophthal.2021.03.010","volume":"66","author":"P Aragona","year":"2021","unstructured":"Aragona P, Baudouin C, Benitez Del Castillo JM, Messmer E, Barabino S, Merayo-Lloves J, et al. The ocular microbiome and microbiota and their effects on ocular surface pathophysiology and disorders. Surv Ophthalmol. 2021;66(6):907\u201325. https:\/\/doi.org\/10.1016\/j.survophthal.2021.03.010.","journal-title":"Surv Ophthalmol"},{"issue":"3","key":"3620_CR13","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1046\/j.1466-822X.2003.00015.x","volume":"12","author":"IF Spellerberg","year":"2003","unstructured":"Spellerberg IF, Fedor PJ. A tribute to Claude Shannon (1916\u20132001) and a plea for more rigorous use of species richness, species diversity and the \u2018Shannon\u2013Wiener\u2019 Index. Glob Ecol Biogeogr. 2003;12(3):177\u20139. https:\/\/doi.org\/10.1046\/j.1466-822X.2003.00015.x.","journal-title":"Glob Ecol Biogeogr"},{"issue":"1","key":"3620_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-77864-y","volume":"15","author":"I Cassol","year":"2025","unstructured":"Cassol I, Ibanez M, Bustamante JP. Key features and guidelines for the application of microbial alpha diversity metrics. Sci Rep. 2025;15(1):622. https:\/\/doi.org\/10.1038\/s41598-024-77864-y.","journal-title":"Sci Rep"},{"issue":"7","key":"3620_CR15","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/s41579-018-0029-9","volume":"16","author":"R Knight","year":"2018","unstructured":"Knight R, Vrbanac A, Taylor BC, Aksenov A, Callewaert C, Debelius J, et al. Best practices for analysing microbiomes. Nat Rev Microbiol. 2018;16(7):410\u201322. https:\/\/doi.org\/10.1038\/s41579-018-0029-9.","journal-title":"Nat Rev Microbiol"},{"issue":"5","key":"3620_CR16","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.70168","volume":"6","author":"Y Shen","year":"2025","unstructured":"Shen Y, Fan N, Ma SX, Cheng X, Yang X, Wang G. Gut microbiota dysbiosis: pathogenesis, diseases, prevention, and therapy. MedComm. 2025;6(5):e70168. https:\/\/doi.org\/10.1002\/mco2.70168.","journal-title":"MedComm"},{"key":"3620_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/nu14142872","author":"I Sharon","year":"2022","unstructured":"Sharon I, Quijada NM, Pasolli E, Fabbrini M, Vitali F, Agamennone V, et al. The core human microbiome: does it exist and how can we find it? A critical review of the concept. Nutrients. 2022. https:\/\/doi.org\/10.3390\/nu14142872.","journal-title":"Nutrients"},{"key":"3620_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmni.2019.100622","volume":"34","author":"M Bonnet","year":"2020","unstructured":"Bonnet M, Lagier JC, Raoult D, Khelaifia S. Bacterial culture through selective and non-selective conditions: the evolution of culture media in clinical microbiology. New Microbes New Infect. 2020;34:100622. https:\/\/doi.org\/10.1016\/j.nmni.2019.100622.","journal-title":"New Microbes New Infect"},{"issue":"4","key":"3620_CR19","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/BF02010671","volume":"8","author":"HS Xu","year":"1982","unstructured":"Xu HS, Roberts N, Singleton FL, Attwell RW, Grimes DJ, Colwell RR. Survival and viability of nonculturableEscherichia coli andVibrio cholerae in the estuarine and marine environment. Microb Ecol. 1982;8(4):313\u201323. https:\/\/doi.org\/10.1007\/BF02010671.","journal-title":"Microb Ecol"},{"issue":"9","key":"3620_CR20","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1038\/nbt0985-817","volume":"3","author":"RR Colwell","year":"1985","unstructured":"Colwell RR, Brayton PR, Grimes DJ, Roszak DB, Huq SA, Palmer LM. Viable but non-culturable Vibrio cholerae and related pathogens in the environment: implications for release of genetically engineered microorganisms. Nat Biotechnol. 1985;3(9):817\u201320. https:\/\/doi.org\/10.1038\/nbt0985-817.","journal-title":"Nat Biotechnol"},{"issue":"6","key":"3620_CR21","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1007\/s10096-019-03520-3","volume":"38","author":"SA Boers","year":"2019","unstructured":"Boers SA, Jansen R, Hays JP. Understanding and overcoming the pitfalls and biases of next-generation sequencing (NGS) methods for use in the routine clinical microbiological diagnostic laboratory. Eur J Clin Microbiol Infect Dis. 2019;38(6):1059\u201370. https:\/\/doi.org\/10.1007\/s10096-019-03520-3.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"3620_CR22","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.bbi.2023.09.022","volume":"115","author":"AJ McGuinness","year":"2024","unstructured":"McGuinness AJ, Stinson LF, Snelson M, Loughman A, Stringer A, Hannan AJ, et al. From hype to hope: considerations in conducting robust microbiome science. Brain Behav Immun. 2024;115:120\u201330. https:\/\/doi.org\/10.1016\/j.bbi.2023.09.022.","journal-title":"Brain Behav Immun"},{"key":"3620_CR23","doi-asserted-by":"publisher","first-page":"826370","DOI":"10.3389\/fbinf.2021.826370","volume":"1","author":"B Hu","year":"2021","unstructured":"Hu B, Canon S, Eloe-Fadrosh EA, Anubhav, Babinski M, Corilo Y, et al. Challenges in bioinformatics workflows for processing microbiome omics data at scale. Front Bioinform. 2021;1:826370. https:\/\/doi.org\/10.3389\/fbinf.2021.826370.","journal-title":"Front Bioinform."},{"issue":"1","key":"3620_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28034-z","volume":"13","author":"JT Nearing","year":"2022","unstructured":"Nearing JT, Douglas GM, Hayes MG, MacDonald J, Desai DK, Allward N, et al. Microbiome differential abundance methods produce different results across 38 datasets. Nat Commun. 2022;13(1):342. https:\/\/doi.org\/10.1038\/s41467-022-28034-z.","journal-title":"Nat Commun"},{"key":"3620_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms7010014","author":"E Rinninella","year":"2019","unstructured":"Rinninella E, Raoul P, Cintoni M, Franceschi F, Miggiano GAD, Gasbarrini A, et al. What is the healthy gut microbiota composition? A changing ecosystem across age, environment, diet, and diseases. Microorganisms. 2019. https:\/\/doi.org\/10.3390\/microorganisms7010014.","journal-title":"Microorganisms"},{"issue":"7164","key":"3620_CR26","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1038\/nature06244","volume":"449","author":"PJ Turnbaugh","year":"2007","unstructured":"Turnbaugh PJ, Ley RE, Hamady M, Fraser-Liggett CM, Knight R, Gordon JI. The human microbiome project. Nature. 2007;449(7164):804\u201310. https:\/\/doi.org\/10.1038\/nature06244.","journal-title":"Nature"},{"key":"3620_CR27","doi-asserted-by":"publisher","unstructured":"Raising standards in microbiome research. Nat Microbiol. 2016;1(7):16112. https:\/\/doi.org\/10.1038\/nmicrobiol.2016.112","DOI":"10.1038\/nmicrobiol.2016.112"},{"issue":"11","key":"3620_CR28","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1038\/s41591-021-01552-x","volume":"27","author":"C Mirzayi","year":"2021","unstructured":"Mirzayi C, Renson A, Genomic Standards C, Massive A, Quality Control S, Zohra F, et al. Reporting guidelines for human microbiome research: the STORMS checklist. Nat Med. 2021;27(11):1885\u201392. https:\/\/doi.org\/10.1038\/s41591-021-01552-x.","journal-title":"Nat Med"},{"issue":"3","key":"3620_CR29","doi-asserted-by":"publisher","DOI":"10.1128\/mSystems.00021-16","volume":"1","author":"SJ Song","year":"2016","unstructured":"Song SJ, Amir A, Metcalf JL, Amato KR, Xu ZZ, Humphrey G, et al. Preservation methods differ in fecal microbiome stability, affecting suitability for field studies. mSystems. 2016;1(3):10.1128\/msystems.00021-16. https:\/\/doi.org\/10.1128\/mSystems.00021-16.","journal-title":"mSystems"},{"issue":"3","key":"3620_CR30","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1093\/cvr\/cvaa128","volume":"117","author":"TUP Bartolomaeus","year":"2021","unstructured":"Bartolomaeus TUP, Birkner T, Bartolomaeus H, Lober U, Avery EG, Mahler A, et al. Quantifying technical confounders in microbiome studies. Cardiovasc Res. 2021;117(3):863\u201375. https:\/\/doi.org\/10.1093\/cvr\/cvaa128.","journal-title":"Cardiovasc Res"},{"key":"3620_CR31","doi-asserted-by":"publisher","unstructured":"Toussaint B, Pineiro A, Rodr\u00edguez Alonso R. Challenges and current actions to address standardisation of the human gut microbiome analysis. 2024. https:\/\/doi.org\/10.2760\/8748720","DOI":"10.2760\/8748720"},{"issue":"4","key":"3620_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.xops.2023.100408","volume":"3","author":"A Chowdhary","year":"2023","unstructured":"Chowdhary A, Van Gelder RN, Sundararajan M. Methodologic considerations for studying the ocular surface microbiome. Ophthalmol Sci (Tokyo). 2023;3(4):100408. https:\/\/doi.org\/10.1016\/j.xops.2023.100408.","journal-title":"Ophthalmol Sci (Tokyo)"},{"issue":"7","key":"3620_CR33","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1080\/02713683.2019.1570526","volume":"44","author":"J Ozkan","year":"2019","unstructured":"Ozkan J, Willcox MD. The ocular microbiome: molecular characterisation of a unique and low microbial environment. Curr Eye Res. 2019;44(7):685\u201394. https:\/\/doi.org\/10.1080\/02713683.2019.1570526.","journal-title":"Curr Eye Res"},{"key":"3620_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2025.110046","volume":"190","author":"V Rizzuto","year":"2025","unstructured":"Rizzuto V, Settino M, Stroffolini G, Covello G, Vanags J, Naccarato M, et al. Ocular surface microbiome: influences of physiological, environmental, and lifestyle factors. Comput Biol Med. 2025;190:110046. https:\/\/doi.org\/10.1016\/j.compbiomed.2025.110046.","journal-title":"Comput Biol Med"},{"issue":"1","key":"3620_CR35","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1146\/annurev.mi.31.100177.000543","volume":"31","author":"DC Savage","year":"1977","unstructured":"Savage DC. Microbial ecology of the gastrointestinal tract. Annu Rev Microbiol. 1977;31(1):107\u201333. https:\/\/doi.org\/10.1146\/annurev.mi.31.100177.000543.","journal-title":"Annu Rev Microbiol"},{"issue":"10","key":"3620_CR36","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/nrgastro.2012.156","volume":"9","author":"HJ Flint","year":"2012","unstructured":"Flint HJ, Scott KP, Louis P, Duncan SH. The role of the gut microbiota in nutrition and health. Nat Rev Gastroenterol Hepatol. 2012;9(10):577\u201389. https:\/\/doi.org\/10.1038\/nrgastro.2012.156.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"3620_CR37","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1097\/MOG.0b013e3282f2b0e8","volume":"24","author":"DN Frank","year":"2008","unstructured":"Frank DN, Pace NR. Gastrointestinal microbiology enters the metagenomics era. Curr Opin Gastroenterol. 2008;24(1):4\u201310. https:\/\/doi.org\/10.1097\/MOG.0b013e3282f2b0e8.","journal-title":"Curr Opin Gastroenterol"},{"issue":"11","key":"3620_CR38","doi-asserted-by":"publisher","first-page":"4593","DOI":"10.1167\/iovs.17-22119","volume":"58","author":"A Kugadas","year":"2017","unstructured":"Kugadas A, Wright Q, Geddes-McAlister J, Gadjeva M. Role of microbiota in strengthening Ocular Mucosal Barrier Function through secretory IgA. Investig Ophthalmol Vis Sci. 2017;58(11):4593\u2013600. https:\/\/doi.org\/10.1167\/iovs.17-22119.","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"17","key":"3620_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241713338","volume":"24","author":"LIM Campagnoli","year":"2023","unstructured":"Campagnoli LIM, Varesi A, Barbieri A, Marchesi N, Pascale A. Targeting the gut\u2013eye axis: an emerging strategy to face ocular diseases. Int J Mol Sci. 2023;24(17):13338.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"3620_CR40","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s40123-020-00278-2","volume":"9","author":"JL Floyd","year":"2020","unstructured":"Floyd JL, Grant MB. The gut\u2013eye axis: lessons learned from murine models. Ophthalmol Ther. 2020;9(3):499\u2013513. https:\/\/doi.org\/10.1007\/s40123-020-00278-2.","journal-title":"Ophthalmol Ther"},{"key":"3620_CR41","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/978-981-97-0048-6_10","volume-title":"Animal models in research","author":"S Kumar","year":"2024","unstructured":"Kumar S, Atul PK. Animal models for gut microbiome research. In: Vijayakumar Sreelatha H, Patel S, Nagarajan P, editors. Animal models in research. Singapore: Springer; 2024. p. 255\u201381."},{"key":"3620_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2025.1644187","volume":"15","author":"X Huang","year":"2025","unstructured":"Huang X, Yu Y, Tian N, Huang J, Zhang X, Yu R. Human microbiota-associated animal models: a review. Front Cell Infect Microbiol. 2025;15:1644187. https:\/\/doi.org\/10.3389\/fcimb.2025.1644187.","journal-title":"Front Cell Infect Microbiol"},{"issue":"20","key":"3620_CR43","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph17207618","volume":"17","author":"Z Al Bander","year":"2020","unstructured":"Al Bander Z, Nitert MD, Mousa A, Naderpoor N. The Gut Microbiota and inflammation: an overview. Int J Environ Res Public Health. 2020;17(20):7618. https:\/\/doi.org\/10.3390\/ijerph17207618.","journal-title":"Int J Environ Res Public Health"},{"issue":"4","key":"3620_CR44","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.66.4.21","volume":"66","author":"Z Parekh","year":"2025","unstructured":"Parekh Z, Xiao J, Mani A, Evans Q, Phung C, Barba HA, et al. Fecal microbial profiles and short-chain fatty acid\/bile acid metabolomics in patients with age-related macular degeneration: a pilot study. Investig Ophthalmol Vis Sci. 2025;66(4):21. https:\/\/doi.org\/10.1167\/iovs.66.4.21.","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"9","key":"3620_CR45","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.66.9.6","volume":"66","author":"X Cui","year":"2025","unstructured":"Cui X, Yi C, Liu J, Qi J, Deng W, Yuan X, et al. The Gut Microbial System responds to retinal injury and modulates the outcomes by regulating Innate Immune Activation. Investig Ophthalmol Vis Sci. 2025;66(9):6. https:\/\/doi.org\/10.1167\/iovs.66.9.6.","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"2","key":"3620_CR46","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s11739-023-03374-w","volume":"19","author":"F Di Vincenzo","year":"2024","unstructured":"Di Vincenzo F, Del Gaudio A, Petito V, Lopetuso LR, Scaldaferri F. Gut microbiota, intestinal permeability, and systemic inflammation: a narrative review. Intern Emerg Med. 2024;19(2):275\u201393. https:\/\/doi.org\/10.1007\/s11739-023-03374-w.","journal-title":"Intern Emerg Med"},{"key":"3620_CR47","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28052236","author":"S Pan","year":"2023","unstructured":"Pan S, Liu M, Xu H, Chuan J, Yang Z. Lipopolysaccharide activating NF-kB signaling by regulates HTRA1 expression in human retinal pigment epithelial cells. Molecules. 2023. https:\/\/doi.org\/10.3390\/molecules28052236.","journal-title":"Molecules"},{"issue":"1","key":"3620_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-022-02296-z","volume":"22","author":"X Qin","year":"2022","unstructured":"Qin X, Zou H. The role of lipopolysaccharides in diabetic retinopathy. BMC Ophthalmol. 2022;22(1):86. https:\/\/doi.org\/10.1186\/s12886-022-02296-z.","journal-title":"BMC Ophthalmol"},{"issue":"1","key":"3620_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2021.112581","volume":"403","author":"F Hikage","year":"2021","unstructured":"Hikage F, Lennikov A, Mukwaya A, Lachota M, Ida Y, Utheim TP, et al. NF-\u03baB activation in retinal microglia is involved in the inflammatory and neovascularization signaling in laser-induced choroidal neovascularization in mice. Exp Cell Res. 2021;403(1):112581. https:\/\/doi.org\/10.1016\/j.yexcr.2021.112581.","journal-title":"Exp Cell Res"},{"issue":"11","key":"3620_CR50","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0007945","volume":"4","author":"W Ma","year":"2009","unstructured":"Ma W, Zhao L, Fontainhas AM, Fariss RN, Wong WT. Microglia in the mouse retina alter the structure and function of retinal pigmented epithelial cells: a potential cellular interaction relevant to AMD. PLoS ONE. 2009;4(11):e7945. https:\/\/doi.org\/10.1371\/journal.pone.0007945.","journal-title":"PLoS ONE"},{"issue":"1","key":"3620_CR51","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1080\/09273948.2022.2147547","volume":"32","author":"I Tsioti","year":"2024","unstructured":"Tsioti I, Steiner BL, Escher P, Zinkernagel MS, Benz PM, Kokona D. Systemic Lipopolysaccharide exposure exacerbates choroidal neovascularization in mice. Ocul Immunol Inflamm. 2024;32(1):19\u201330. https:\/\/doi.org\/10.1080\/09273948.2022.2147547.","journal-title":"Ocul Immunol Inflamm"},{"issue":"12","key":"3620_CR52","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.15252\/emmm.201606531","volume":"8","author":"EM Andriessen","year":"2016","unstructured":"Andriessen EM, Wilson AM, Mawambo G, Dejda A, Miloudi K, Sennlaub F, et al. Gut microbiota influences pathological angiogenesis in obesity-driven choroidal neovascularization. EMBO Mol Med. 2016;8(12):1366\u201379. https:\/\/doi.org\/10.15252\/emmm.201606531.","journal-title":"EMBO Mol Med"},{"issue":"22","key":"3620_CR53","doi-asserted-by":"publisher","first-page":"E4472","DOI":"10.1073\/pnas.1702302114","volume":"114","author":"S Rowan","year":"2017","unstructured":"Rowan S, Jiang S, Korem T, Szymanski J, Chang ML, Szelog J, et al. Involvement of a gut-retina axis in protection against dietary glycemia-induced age-related macular degeneration. Proc Natl Acad Sci USA. 2017;114(22):E4472\u201381. https:\/\/doi.org\/10.1073\/pnas.1702302114.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"3620_CR54","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s40168-022-01243-w","volume":"10","author":"A Parker","year":"2022","unstructured":"Parker A, Romano S, Ansorge R, Aboelnour A, Le Gall G, Savva GM, et al. Fecal microbiota transfer between young and aged mice reverses hallmarks of the aging gut, eye, and brain. Microbiome. 2022;10(1):68. https:\/\/doi.org\/10.1186\/s40168-022-01243-w.","journal-title":"Microbiome"},{"key":"3620_CR55","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23179676","author":"JY Zhang","year":"2022","unstructured":"Zhang JY, Xie B, Barba H, Nadeem U, Movahedan A, Deng N, et al. Absence of gut microbiota is associated with RPE\/choroid transcriptomic changes related to age-related macular degeneration pathobiology and decreased choroidal neovascularization. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms23179676.","journal-title":"Int J Mol Sci"},{"key":"3620_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115276","volume":"165","author":"H Duan","year":"2023","unstructured":"Duan H, Wang L, Huangfu M, Li H. The impact of microbiota-derived short-chain fatty acids on macrophage activities in disease: mechanisms and therapeutic potentials. Biomed Pharmacother. 2023;165:115276. https:\/\/doi.org\/10.1016\/j.biopha.2023.115276.","journal-title":"Biomed Pharmacother"},{"key":"3620_CR57","doi-asserted-by":"publisher","DOI":"10.3390\/cells11223535","author":"M Boyce","year":"2022","unstructured":"Boyce M, Xin Y, Chowdhury O, Shang P, Liu H, Koontz V, et al. Microglia-neutrophil interactions drive dry AMD-like pathology in a mouse model. Cells. 2022. https:\/\/doi.org\/10.3390\/cells11223535.","journal-title":"Cells"},{"issue":"4","key":"3620_CR58","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/s0014-4835(02)00332-9","volume":"76","author":"N Gupta","year":"2003","unstructured":"Gupta N, Brown KE, Milam AH. Activated microglia in human retinitis pigmentosa, late-onset retinal degeneration, and age-related macular degeneration. Exp Eye Res. 2003;76(4):463\u201371. https:\/\/doi.org\/10.1016\/s0014-4835(02)00332-9.","journal-title":"Exp Eye Res"},{"issue":"1","key":"3620_CR59","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1159\/000484907","volume":"44","author":"J Chen","year":"2017","unstructured":"Chen J, Wang W, Li Q. Increased Th1\/Th17 responses contribute to low-grade inflammation in age-related macular degeneration. Cell Physiol Biochem. 2017;44(1):357\u201367. https:\/\/doi.org\/10.1159\/000484907.","journal-title":"Cell Physiol Biochem"},{"key":"3620_CR60","doi-asserted-by":"publisher","DOI":"10.1038\/srep40826","volume":"7","author":"MS Zinkernagel","year":"2017","unstructured":"Zinkernagel MS, Zysset-Burri DC, Keller I, Berger LE, Leichtle AB, Largiader CR, et al. Association of the intestinal microbiome with the development of neovascular age-related macular degeneration. Sci Rep. 2017;7:40826. https:\/\/doi.org\/10.1038\/srep40826.","journal-title":"Sci Rep"},{"key":"3620_CR61","first-page":"610","volume":"25","author":"A Daruich","year":"2019","unstructured":"Daruich A, Picard E, Boatright JH, Behar-Cohen F. Review: the bile acids urso- and tauroursodeoxycholic acid as neuroprotective therapies in retinal disease. Mol Vis. 2019;25:610\u201324.","journal-title":"Mol Vis"},{"issue":"1","key":"3620_CR62","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1111\/j.1471-4159.2010.07092.x","volume":"116","author":"BC Oveson","year":"2011","unstructured":"Oveson BC, Iwase T, Hackett SF, Lee SY, Usui S, Sedlak TW, et al. Constituents of bile, bilirubin and TUDCA, protect against oxidative stress-induced retinal degeneration. J Neurochem. 2011;116(1):144\u201353. https:\/\/doi.org\/10.1111\/j.1471-4159.2010.07092.x.","journal-title":"J Neurochem"},{"issue":"1","key":"3620_CR63","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1021\/pr1008898","volume":"10","author":"WL Liao","year":"2011","unstructured":"Liao WL, Heo GY, Dodder NG, Reem RE, Mast N, Huang S, et al. Quantification of cholesterol-metabolizing P450s CYP27A1 and CYP46A1 in neural tissues reveals a lack of enzyme-product correlations in human retina but not human brain. J Proteome Res. 2011;10(1):241\u20138. https:\/\/doi.org\/10.1021\/pr1008898.","journal-title":"J Proteome Res"},{"issue":"9","key":"3620_CR64","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1016\/j.ajpath.2014.05.024","volume":"184","author":"A Saadane","year":"2014","unstructured":"Saadane A, Mast N, Charvet CD, Omarova S, Zheng W, Huang SS, et al. Retinal and nonocular abnormalities in Cyp27a1(-\/-)Cyp46a1(-\/-) mice with dysfunctional metabolism of cholesterol. Am J Pathol. 2014;184(9):2403\u201319. https:\/\/doi.org\/10.1016\/j.ajpath.2014.05.024.","journal-title":"Am J Pathol"},{"key":"3620_CR65","doi-asserted-by":"publisher","DOI":"10.1038\/s41525-020-00141-0","volume":"5","author":"DC Zysset-Burri","year":"2020","unstructured":"Zysset-Burri DC, Keller I, Berger LE, Largiader CR, Wittwer M, Wolf S, et al. Associations of the intestinal microbiome with the complement system in neovascular age-related macular degeneration. npj Genom Med. 2020;5:34. https:\/\/doi.org\/10.1038\/s41525-020-00141-0.","journal-title":"npj Genom Med"},{"key":"3620_CR66","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.preteyeres.2017.09.001","volume":"62","author":"CB Toomey","year":"2018","unstructured":"Toomey CB, Johnson LV, Bowes Rickman C. Complement factor H in AMD: bridging genetic associations and pathobiology. Prog Retin Eye Res. 2018;62:38\u201357. https:\/\/doi.org\/10.1016\/j.preteyeres.2017.09.001.","journal-title":"Prog Retin Eye Res"},{"issue":"13","key":"3620_CR67","doi-asserted-by":"publisher","first-page":"3398","DOI":"10.1016\/j.molimm.2007.02.012","volume":"44","author":"C Skerka","year":"2007","unstructured":"Skerka C, Lauer N, Weinberger AA, Keilhauer CN, Suhnel J, Smith R, et al. Defective complement control of factor H (Y402H) and FHL-1 in age-related macular degeneration. Mol Immunol. 2007;44(13):3398\u2013406. https:\/\/doi.org\/10.1016\/j.molimm.2007.02.012.","journal-title":"Mol Immunol"},{"key":"3620_CR68","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9070763","author":"S Romero-Vazquez","year":"2021","unstructured":"Romero-Vazquez S, Llorens V, Soler-Boronat A, Figueras-Roca M, Adan A, Molins B. Interlink between inflammation and oxidative stress in age-related macular degeneration: role of complement factor H. Biomedicines. 2021. https:\/\/doi.org\/10.3390\/biomedicines9070763.","journal-title":"Biomedicines"},{"issue":"2","key":"3620_CR69","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1038\/s41433-021-01765-x","volume":"36","author":"D Desai","year":"2022","unstructured":"Desai D, Dugel PU. Complement cascade inhibition in geographic atrophy: a review. Eye (Lond). 2022;36(2):294\u2013302. https:\/\/doi.org\/10.1038\/s41433-021-01765-x.","journal-title":"Eye (Lond)"},{"issue":"4","key":"3620_CR70","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/j.cell.2023.12.036","volume":"187","author":"M Wu","year":"2024","unstructured":"Wu M, Zheng W, Song X, Bao B, Wang Y, Ramanan D, et al. Gut complement induced by the microbiota combats pathogens and spares commensals. Cell. 2024;187(4):897-913 e18. https:\/\/doi.org\/10.1016\/j.cell.2023.12.036.","journal-title":"Cell"},{"issue":"8","key":"3620_CR71","doi-asserted-by":"publisher","first-page":"5347","DOI":"10.1167\/iovs.10-7119","volume":"52","author":"M Rutar","year":"2011","unstructured":"Rutar M, Natoli R, Kozulin P, Valter K, Gatenby P, Provis JM. Analysis of complement expression in light-induced retinal degeneration: synthesis and deposition of C3 by microglia\/macrophages is associated with focal photoreceptor degeneration. Investig Ophthalmol Vis Sci. 2011;52(8):5347\u201358. https:\/\/doi.org\/10.1167\/iovs.10-7119.","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"8","key":"3620_CR72","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.1002533","volume":"14","author":"R Sender","year":"2016","unstructured":"Sender R, Fuchs S, Milo R. Revised estimates for the number of human and bacteria cells in the body. PLoS Biol. 2016;14(8):e1002533. https:\/\/doi.org\/10.1371\/journal.pbio.1002533.","journal-title":"PLoS Biol"},{"key":"3620_CR73","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms8071033","author":"F Petrillo","year":"2020","unstructured":"Petrillo F, Pignataro D, Lavano MA, Santella B, Folliero V, Zannella C, et al. Current evidence on the ocular surface microbiota and related diseases. Microorganisms. 2020. https:\/\/doi.org\/10.3390\/microorganisms8071033.","journal-title":"Microorganisms"},{"issue":"11","key":"3620_CR74","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-014-0099-x","volume":"6","author":"Y Zhou","year":"2014","unstructured":"Zhou Y, Holland MJ, Makalo P, Joof H, Roberts CH, Mabey DC, et al. The conjunctival microbiome in health and trachomatous disease: a case control study. Genome Med. 2014;6(11):99. https:\/\/doi.org\/10.1186\/s13073-014-0099-x.","journal-title":"Genome Med"},{"issue":"8","key":"3620_CR75","doi-asserted-by":"publisher","first-page":"5408","DOI":"10.1167\/iovs.10-6939","volume":"52","author":"Q Dong","year":"2011","unstructured":"Dong Q, Brulc JM, Iovieno A, Bates B, Garoutte A, Miller D, et al. Diversity of bacteria at healthy human conjunctiva. Investig Ophthalmol Vis Sci. 2011;52(8):5408\u201313. https:\/\/doi.org\/10.1167\/iovs.10-6939.","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"1","key":"3620_CR76","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-10494-9","volume":"7","author":"J Ozkan","year":"2017","unstructured":"Ozkan J, Nielsen S, Diez-Vives C, Coroneo M, Thomas T, Willcox M. Temporal stability and composition of the ocular surface microbiome. Sci Rep. 2017;7(1):9880. https:\/\/doi.org\/10.1038\/s41598-017-10494-9.","journal-title":"Sci Rep"},{"issue":"7","key":"3620_CR77","doi-asserted-by":"publisher","first-page":"643 e7","DOI":"10.1016\/j.cmi.2016.04.008","volume":"22","author":"Y Huang","year":"2016","unstructured":"Huang Y, Yang B, Li W. Defining the normal core microbiome of conjunctival microbial communities. Clin Microbiol Infect. 2016;22(7):643 e7-e12. https:\/\/doi.org\/10.1016\/j.cmi.2016.04.008.","journal-title":"Clin Microbiol Infect"},{"issue":"9","key":"3620_CR78","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.66.9.40","volume":"66","author":"SC Morandi","year":"2025","unstructured":"Morandi SC, Uldry AC, Eldridge N, Kreuzer M, Herzog EL, Zinkernagel M, et al. Toward the characterization of the human core ocular surface microbiome. Investig Ophthalmol Vis Sci. 2025;66(9):40. https:\/\/doi.org\/10.1167\/iovs.66.9.40.","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"11","key":"3620_CR79","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1016\/j.ajpath.2023.05.004","volume":"193","author":"MJ Zilliox","year":"2023","unstructured":"Zilliox MJ, Bouchard CS. The microbiome, ocular surface, and corneal disorders. Am J Pathol. 2023;193(11):1648\u201361. https:\/\/doi.org\/10.1016\/j.ajpath.2023.05.004.","journal-title":"Am J Pathol"},{"issue":"1","key":"3620_CR80","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.immuni.2017.06.014","volume":"47","author":"AJ St Leger","year":"2017","unstructured":"St Leger AJ, Desai JV, Drummond RA, Kugadas A, Almaghrabi F, Silver P, et al. An ocular commensal protects against corneal infection by driving an interleukin-17 response from mucosal gammadelta T cells. Immunity. 2017;47(1):148-58e5. https:\/\/doi.org\/10.1016\/j.immuni.2017.06.014.","journal-title":"Immunity"},{"issue":"2","key":"3620_CR81","doi-asserted-by":"publisher","first-page":"e144","DOI":"10.1016\/S2214-109X(20)30489-7","volume":"9","author":"Blindness GBD","year":"2021","unstructured":"Blindness GBD, Vision Impairment C, Vision Loss Expert Group of the Global Burden of Disease S. Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the right to sight: an analysis for the Global Burden of Disease Study. Lancet Glob Health. 2021;9(2):e144\u201360. https:\/\/doi.org\/10.1016\/S2214-109X(20)30489-7.","journal-title":"Lancet Glob Health"},{"issue":"3","key":"3620_CR82","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1136\/bjo.2005.081224","volume":"90","author":"HA Quigley","year":"2006","unstructured":"Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006;90(3):262\u20137. https:\/\/doi.org\/10.1136\/bjo.2005.081224.","journal-title":"Br J Ophthalmol"},{"issue":"11","key":"3620_CR83","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1016\/j.ophtha.2014.05.013","volume":"121","author":"YC Tham","year":"2014","unstructured":"Tham YC, Li X, Wong TY, Quigley HA, Aung T, Cheng CY. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology. 2014;121(11):2081\u201390. https:\/\/doi.org\/10.1016\/j.ophtha.2014.05.013.","journal-title":"Ophthalmology"},{"issue":"11","key":"3620_CR84","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1016\/j.ophtha.2007.03.016","volume":"114","author":"MC Leske","year":"2007","unstructured":"Leske MC, Heijl A, Hyman L, Bengtsson B, Dong L, Yang Z. Predictors of long-term progression in the early manifest glaucoma trial. Ophthalmology. 2007;114(11):1965\u201372. https:\/\/doi.org\/10.1016\/j.ophtha.2007.03.016.","journal-title":"Ophthalmology"},{"issue":"10","key":"3620_CR85","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1016\/j.ophtha.2007.04.003","volume":"114","author":"B Nemesure","year":"2007","unstructured":"Nemesure B, Honkanen R, Hennis A, Wu SY, Leske MC, Barbados Eye Studies G. Incident open-angle glaucoma and intraocular pressure. Ophthalmology. 2007;114(10):1810\u20135. https:\/\/doi.org\/10.1016\/j.ophtha.2007.04.003.","journal-title":"Ophthalmology"},{"issue":"4","key":"3620_CR86","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.ajo.2009.03.024","volume":"148","author":"F Topouzis","year":"2009","unstructured":"Topouzis F, Harris A, Wilson MR, Koskosas A, Founti P, Yu F, et al. Increased likelihood of glaucoma at the same screening intraocular pressure in subjects with pseudoexfoliation: the Thessaloniki Eye Study. Am J Ophthalmol. 2009;148(4):606-13 e1. https:\/\/doi.org\/10.1016\/j.ajo.2009.03.024.","journal-title":"Am J Ophthalmol"},{"issue":"9","key":"3620_CR87","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1016\/j.ophtha.2011.01.047","volume":"118","author":"DC Musch","year":"2011","unstructured":"Musch DC, Gillespie BW, Niziol LM, Lichter PR, Varma R, Group CS. Intraocular pressure control and long-term visual field loss in the Collaborative Initial Glaucoma Treatment Study. Ophthalmology. 2011;118(9):1766\u201373. https:\/\/doi.org\/10.1016\/j.ophtha.2011.01.047.","journal-title":"Ophthalmology"},{"issue":"4","key":"3620_CR88","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1002\/cne.22516","volume":"519","author":"A Bosco","year":"2011","unstructured":"Bosco A, Steele MR, Vetter ML. Early microglia activation in a mouse model of chronic glaucoma. J Comp Neurol. 2011;519(4):599\u2013620. https:\/\/doi.org\/10.1002\/cne.22516.","journal-title":"J Comp Neurol"},{"issue":"12","key":"3620_CR89","doi-asserted-by":"publisher","first-page":"6448","DOI":"10.1167\/iovs.10-5284","volume":"51","author":"A Ebneter","year":"2010","unstructured":"Ebneter A, Casson RJ, Wood JP, Chidlow G. Microglial activation in the visual pathway in experimental glaucoma: spatiotemporal characterization and correlation with axonal injury. Investig Ophthalmol Vis Sci. 2010;51(12):6448\u201360. https:\/\/doi.org\/10.1167\/iovs.10-5284.","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"3","key":"3620_CR90","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1167\/iovs.05-0830","volume":"47","author":"K Stasi","year":"2006","unstructured":"Stasi K, Nagel D, Yang X, Wang RF, Ren L, Podos SM, et al. Complement component 1Q (C1Q) upregulation in retina of murine, primate, and human glaucomatous eyes. Investig Ophthalmol Vis Sci. 2006;47(3):1024\u20139. https:\/\/doi.org\/10.1167\/iovs.05-0830.","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"11","key":"3620_CR91","doi-asserted-by":"publisher","first-page":"5697","DOI":"10.1167\/iovs.10-5407","volume":"51","author":"C Luo","year":"2010","unstructured":"Luo C, Yang X, Kain AD, Powell DW, Kuehn MH, Tezel G. Glaucomatous tissue stress and the regulation of immune response through glial Toll-like receptor signaling. Investig Ophthalmol Vis Sci. 2010;51(11):5697\u2013707. https:\/\/doi.org\/10.1167\/iovs.10-5407.","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"2","key":"3620_CR92","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.jmii.2018.12.006","volume":"52","author":"T Poyomtip","year":"2019","unstructured":"Poyomtip T. Roles of toll-like receptor 4 for cellular pathogenesis in primary open-angle glaucoma: a potential therapeutic strategy. J Microbiol Immunol Infect. 2019;52(2):201\u20136. https:\/\/doi.org\/10.1016\/j.jmii.2018.12.006.","journal-title":"J Microbiol Immunol Infect"},{"issue":"5","key":"3620_CR93","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.survophthal.2021.02.003","volume":"66","author":"L Quaranta","year":"2021","unstructured":"Quaranta L, Bruttini C, Micheletti E, Konstas AGP, Michelessi M, Oddone F, et al. Glaucoma and neuroinflammation: an overview. Surv Ophthalmol. 2021;66(5):693\u2013713. https:\/\/doi.org\/10.1016\/j.survophthal.2021.02.003.","journal-title":"Surv Ophthalmol"},{"issue":"10","key":"3620_CR94","doi-asserted-by":"publisher","DOI":"10.1002\/cti2.1180","volume":"9","author":"D Wakefield","year":"2020","unstructured":"Wakefield D, Wildner G. Is glaucoma an autoimmune disease? Clin Transl Immunol. 2020;9(10):e1180. https:\/\/doi.org\/10.1002\/cti2.1180.","journal-title":"Clin Transl Immunol"},{"issue":"46","key":"3620_CR95","doi-asserted-by":"publisher","first-page":"12085","DOI":"10.1523\/JNEUROSCI.3200-08.2008","volume":"28","author":"MB Wax","year":"2008","unstructured":"Wax MB, Tezel G, Yang J, Peng G, Patil RV, Agarwal N, et al. Induced autoimmunity to heat shock proteins elicits glaucomatous loss of retinal ganglion cell neurons via activated T-cell-derived Fas-ligand. J Neurosci. 2008;28(46):12085\u201396. https:\/\/doi.org\/10.1523\/JNEUROSCI.3200-08.2008.","journal-title":"J Neurosci"},{"issue":"1","key":"3620_CR96","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05681-9","volume":"9","author":"H Chen","year":"2018","unstructured":"Chen H, Cho KS, Vu THK, Shen CH, Kaur M, Chen G, et al. Commensal microflora-induced T cell responses mediate progressive neurodegeneration in glaucoma. Nat Commun. 2018;9(1):3209. https:\/\/doi.org\/10.1038\/s41467-018-05681-9.","journal-title":"Nat Commun"},{"key":"3620_CR97","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.968992","volume":"12","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Zhou X, Lu Y. Gut microbiota and derived metabolomic profiling in glaucoma with progressive neurodegeneration. Front Cell Infect Microbiol. 2022;12:968992. https:\/\/doi.org\/10.3389\/fcimb.2022.968992.","journal-title":"Front Cell Infect Microbiol"},{"issue":"2","key":"3620_CR98","doi-asserted-by":"publisher","DOI":"10.1002\/mef2.28","volume":"1","author":"S Chen","year":"2022","unstructured":"Chen S, Wang Y, Liu Y, Li F, Chen Y, Fang X, et al. Dysbiosis of gut microbiome contributes to glaucoma pathogenesis. MedComm \u2013 Future Med. 2022;1(2):e28. https:\/\/doi.org\/10.1002\/mef2.28.","journal-title":"MedComm \u2013 Future Med"},{"key":"3620_CR99","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2020.107921","volume":"191","author":"H Gong","year":"2020","unstructured":"Gong H, Zhang S, Li Q, Zuo C, Gao X, Zheng B, et al. Gut microbiota compositional profile and serum metabolic phenotype in patients with primary open-angle glaucoma. Exp Eye Res. 2020;191:107921. https:\/\/doi.org\/10.1016\/j.exer.2020.107921.","journal-title":"Exp Eye Res"},{"issue":"Suppl 1","key":"3620_CR100","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1111\/cns.14165","volume":"29","author":"X Zhao","year":"2023","unstructured":"Zhao X, Xu M, Zhao Z, Wang Y, Liu Y, Zhang T, et al. Bifidobacterium promotes retinal ganglion cell survival by regulating the balance of retinal glial cells. CNS Neurosci Ther. 2023;29(Suppl 1):146\u201360. https:\/\/doi.org\/10.1111\/cns.14165.","journal-title":"CNS Neurosci Ther"},{"key":"3620_CR101","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms10071326","author":"JS Nicholson","year":"2022","unstructured":"Nicholson JS, Landry KS. Oral dysbiosis and neurodegenerative diseases: correlations and potential causations. Microorganisms. 2022. https:\/\/doi.org\/10.3390\/microorganisms10071326.","journal-title":"Microorganisms"},{"issue":"9","key":"3620_CR102","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0104416","volume":"9","author":"K Astafurov","year":"2014","unstructured":"Astafurov K, Elhawy E, Ren L, Dong CQ, Igboin C, Hyman L, et al. Oral microbiome link to neurodegeneration in glaucoma. PLoS ONE. 2014;9(9):e104416. https:\/\/doi.org\/10.1371\/journal.pone.0104416.","journal-title":"PLoS ONE"},{"issue":"4","key":"3620_CR103","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1097\/IJG.0000000000000465","volume":"26","author":"D Polla","year":"2017","unstructured":"Polla D, Astafurov K, Hawy E, Hyman L, Hou W, Danias J. A pilot study to evaluate the oral microbiome and dental health in primary open-angle glaucoma. J Glaucoma. 2017;26(4):320\u20137. https:\/\/doi.org\/10.1097\/IJG.0000000000000465.","journal-title":"J Glaucoma"},{"issue":"1","key":"3620_CR104","doi-asserted-by":"publisher","first-page":"1962125","DOI":"10.1080\/20002297.2021.1962125","volume":"13","author":"BW Yoon","year":"2021","unstructured":"Yoon BW, Lim SH, Shin JH, Lee JW, Lee Y, Seo JH. Analysis of oral microbiome in glaucoma patients using machine learning prediction models. J Oral Microbiol. 2021;13(1):1962125. https:\/\/doi.org\/10.1080\/20002297.2021.1962125.","journal-title":"J Oral Microbiol"},{"issue":"1","key":"3620_CR105","doi-asserted-by":"publisher","first-page":"17568","DOI":"10.1038\/s41598-020-74589-6","volume":"10","author":"KT Sun","year":"2020","unstructured":"Sun KT, Shen TC, Chen SC, Chang CL, Li CH, Li X, et al. Periodontitis and the subsequent risk of glaucoma: results from the real-world practice. Sci Rep. 2020;10(1):17568. https:\/\/doi.org\/10.1038\/s41598-020-74589-6.","journal-title":"Sci Rep"},{"issue":"10","key":"3620_CR106","doi-asserted-by":"publisher","first-page":"3055","DOI":"10.1007\/s00417-021-05218-9","volume":"259","author":"SH Lim","year":"2021","unstructured":"Lim SH, Shin JH, Lee JW, Lee Y, Seo JH. Differences in the eyelid and buccal microbiome of glaucoma patients receiving long-term administration of prostaglandin analog drops. Graefes Arch Clin Exp Ophthalmol. 2021;259(10):3055\u201365. https:\/\/doi.org\/10.1007\/s00417-021-05218-9.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"3620_CR107","doi-asserted-by":"publisher","DOI":"10.3390\/nu15092211","author":"W Fusco","year":"2023","unstructured":"Fusco W, Lorenzo MB, Cintoni M, Porcari S, Rinninella E, Kaitsas F, et al. Short-chain fatty-acid-producing bacteria: key components of the human gut microbiota. Nutrients. 2023. https:\/\/doi.org\/10.3390\/nu15092211.","journal-title":"Nutrients"},{"issue":"6","key":"3620_CR108","doi-asserted-by":"publisher","first-page":"2470","DOI":"10.3390\/ijms26062470","volume":"26","author":"E Ciurariu","year":"2025","unstructured":"Ciurariu E, Tirziu AT, Varga NI, Hirtie B, Alexandru A, Ivan CS, et al. Short-chain fatty acids and the gut-retina connection: a systematic review. Int J Mol Sci. 2025;26(6):2470. https:\/\/doi.org\/10.3390\/ijms26062470.","journal-title":"Int J Mol Sci"},{"key":"3620_CR109","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.815347","volume":"14","author":"S Guo","year":"2022","unstructured":"Guo S, Wang H, Yin Y. Microglia polarization from M1 to M2 in neurodegenerative diseases. Front Aging Neurosci. 2022;14:815347. https:\/\/doi.org\/10.3389\/fnagi.2022.815347.","journal-title":"Front Aging Neurosci"},{"issue":"2","key":"3620_CR110","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1167\/iovs.65.2.7","volume":"65","author":"JE Vergroesen","year":"2024","unstructured":"Vergroesen JE, Jarrar ZA, Weiss S, Frost F, Ansari AS, Nguyen P, et al. Glaucoma patients have a lower abundance of butyrate-producing taxa in the gut. Investig Ophthalmol Vis Sci. 2024;65(2):7. https:\/\/doi.org\/10.1167\/iovs.65.2.7.","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"7","key":"3620_CR111","doi-asserted-by":"publisher","first-page":"537","DOI":"10.2174\/138920210793175895","volume":"11","author":"LA Macfarlane","year":"2010","unstructured":"Macfarlane LA, Murphy PR. MicroRNA: biogenesis, function and role in cancer. Curr Genom. 2010;11(7):537\u201361. https:\/\/doi.org\/10.2174\/138920210793175895.","journal-title":"Curr Genom"},{"issue":"1","key":"3620_CR112","doi-asserted-by":"publisher","first-page":"e10","DOI":"10.1111\/aos.13227","volume":"95","author":"J Wang","year":"2017","unstructured":"Wang J, Valiente-Soriano FJ, Nadal-Nicolas FM, Rovere G, Chen S, Huang W, et al. MicroRNA regulation in an animal model of acute ocular hypertension. Acta Ophthalmol. 2017;95(1):e10\u201321. https:\/\/doi.org\/10.1111\/aos.13227.","journal-title":"Acta Ophthalmol"},{"key":"3620_CR113","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241914699","author":"M Dobrzycka","year":"2023","unstructured":"Dobrzycka M, Sulewska A, Biecek P, Charkiewicz R, Karabowicz P, Charkiewicz A, et al. MiRNA studies in glaucoma: a comprehensive review of current knowledge and future perspectives. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms241914699.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"3620_CR114","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s10792-020-01587-y","volume":"41","author":"J Skrzypecki","year":"2021","unstructured":"Skrzypecki J, Izdebska J, Kaminska A, Badowska J, Przybek-Skrzypecka J, Bombuy J, et al. Glaucoma patients have an increased level of trimethylamine, a toxic product of gut bacteria, in the aqueous humor: a pilot study. Int Ophthalmol. 2021;41(1):341\u20137. https:\/\/doi.org\/10.1007\/s10792-020-01587-y.","journal-title":"Int Ophthalmol"},{"key":"3620_CR115","doi-asserted-by":"publisher","DOI":"10.3390\/toxins11090490","author":"K Jaworska","year":"2019","unstructured":"Jaworska K, Hering D, Mosieniak G, Bielak-Zmijewska A, Pilz M, Konwerski M, et al. TMA, a forgotten uremic toxin, but not TMAO, is involved in cardiovascular pathology. Toxins (Basel). 2019. https:\/\/doi.org\/10.3390\/toxins11090490.","journal-title":"Toxins (Basel)"},{"issue":"3","key":"3620_CR116","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/s0889-8553(05)70130-8","volume":"29","author":"JE Everhart","year":"2000","unstructured":"Everhart JE. Recent developments in the epidemiology of Helicobacter pylori. Gastroenterol Clin North Am. 2000;29(3):559\u201378. https:\/\/doi.org\/10.1016\/s0889-8553(05)70130-8.","journal-title":"Gastroenterol Clin North Am"},{"issue":"6","key":"3620_CR117","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/S2468-1253(23)00070-5","volume":"8","author":"Y Li","year":"2023","unstructured":"Li Y, Choi H, Leung K, Jiang F, Graham DY, Leung WK. Global prevalence of Helicobacter pylori infection between 1980 and 2022: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2023;8(6):553\u201364. https:\/\/doi.org\/10.1016\/S2468-1253(23)00070-5.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"29","key":"3620_CR118","doi-asserted-by":"publisher","first-page":"3204","DOI":"10.3748\/wjg.v24.i29.3204","volume":"24","author":"AG Gravina","year":"2018","unstructured":"Gravina AG, Zagari RM, De Musis C, Romano L, Loguercio C, Romano M. Helicobacter pylori and extragastric diseases: a review. World J Gastroenterol. 2018;24(29):3204\u201321. https:\/\/doi.org\/10.3748\/wjg.v24.i29.3204.","journal-title":"World J Gastroenterol"},{"issue":"3","key":"3620_CR119","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/s0161-6420(00)00598-4","volume":"108","author":"J Kountouras","year":"2001","unstructured":"Kountouras J, Mylopoulos N, Boura P, Bessas C, Chatzopoulos D, Venizelos J, et al. Relationship between Helicobacter pylori infection and glaucoma. Ophthalmology. 2001;108(3):599\u2013604. https:\/\/doi.org\/10.1016\/s0161-6420(00)00598-4.","journal-title":"Ophthalmology"},{"issue":"3","key":"3620_CR120","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1159\/000330053","volume":"47","author":"C Zavos","year":"2012","unstructured":"Zavos C, Kountouras J, Sakkias G, Venizelos I, Deretzi G, Arapoglou S. Histological presence of Helicobacter pylori bacteria in the trabeculum and iris of patients with primary open-angle glaucoma. Ophthalmic Res. 2012;47(3):150\u20136. https:\/\/doi.org\/10.1159\/000330053.","journal-title":"Ophthalmic Res"},{"issue":"7 Spec No","key":"3620_CR121","doi-asserted-by":"publisher","first-page":"13","DOI":"10.5539\/gjhs.v6n7p13","volume":"6","author":"V Samarai","year":"2014","unstructured":"Samarai V, Sharifi N, Nateghi S. Association between Helicobacter pylori infection and primary open angle glaucoma. Glob J Health Sci. 2014;6(7 Spec No):13\u20137. https:\/\/doi.org\/10.5539\/gjhs.v6n7p13.","journal-title":"Glob J Health Sci"},{"issue":"11","key":"3620_CR122","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1007\/s00417-003-0779-5","volume":"241","author":"J Kountouras","year":"2003","unstructured":"Kountouras J, Mylopoulos N, Konstas AG, Zavos C, Chatzopoulos D, Boukla A. Increased levels of Helicobacter pylori IgG antibodies in aqueous humor of patients with primary open-angle and exfoliation glaucoma. Graefes Arch Clin Exp Ophthalmol. 2003;241(11):884\u201390. https:\/\/doi.org\/10.1007\/s00417-003-0779-5.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"11","key":"3620_CR123","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1001\/archinte.162.11.1237","volume":"162","author":"J Kountouras","year":"2002","unstructured":"Kountouras J, Mylopoulos N, Chatzopoulos D, Zavos C, Boura P, Konstas AG, et al. Eradication of Helicobacter pylori may be beneficial in the management of chronic open-angle glaucoma. Arch Intern Med. 2002;162(11):1237\u201344. https:\/\/doi.org\/10.1001\/archinte.162.11.1237.","journal-title":"Arch Intern Med"},{"issue":"3","key":"3620_CR124","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1097\/IJG.0b013e31815a34ac","volume":"17","author":"S Kurtz","year":"2008","unstructured":"Kurtz S, Regenbogen M, Goldiner I, Horowitz N, Moshkowitz M. No association between Helicobacter pylori infection or CagA-bearing strains and glaucoma. J Glaucoma. 2008;17(3):223\u20136. https:\/\/doi.org\/10.1097\/IJG.0b013e31815a34ac.","journal-title":"J Glaucoma"},{"issue":"5","key":"3620_CR125","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1016\/S0161-6420(03)00093-9","volume":"110","author":"PH Galloway","year":"2003","unstructured":"Galloway PH, Warner SJ, Morshed MG, Mikelberg FS. Helicobacter pylori infection and the risk for open-angle glaucoma. Ophthalmology. 2003;110(5):922\u20135. https:\/\/doi.org\/10.1016\/S0161-6420(03)00093-9.","journal-title":"Ophthalmology"},{"key":"3620_CR126","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms8060894","author":"M Doulberis","year":"2020","unstructured":"Doulberis M, Papaefthymiou A, Polyzos SA, Bargiotas P, Liatsos C, Srivastava DS, et al. Association between active Helicobacter pylori infection and glaucoma: a systematic review and meta-analysis. Microorganisms. 2020. https:\/\/doi.org\/10.3390\/microorganisms8060894.","journal-title":"Microorganisms"},{"issue":"9","key":"3620_CR127","doi-asserted-by":"publisher","first-page":"5238","DOI":"10.1167\/iovs.15-17059","volume":"56","author":"J Zeng","year":"2015","unstructured":"Zeng J, Liu H, Liu X, Ding C. The relationship between Helicobacter pylori infection and open-angle glaucoma: a meta-analysis. Investig Ophthalmol Vis Sci. 2015;56(9):5238\u201345. https:\/\/doi.org\/10.1167\/iovs.15-17059.","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"1","key":"3620_CR128","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/nyas.14253","volume":"1465","author":"A Papaefthymiou","year":"2020","unstructured":"Papaefthymiou A, Doulberis M, Katsinelos P, Liatsos C, Polyzos SA, Kotronis G, et al. Impact of nitric oxide\u2019s bidirectional role on glaucoma: focus on Helicobacter pylori-related nitrosative stress. Ann N Y Acad Sci. 2020;1465(1):10\u201328. https:\/\/doi.org\/10.1111\/nyas.14253.","journal-title":"Ann N Y Acad Sci"},{"issue":"6","key":"3620_CR129","doi-asserted-by":"publisher","first-page":"C1378","DOI":"10.1152\/ajpcell.00363.2007","volume":"294","author":"WM Dismuke","year":"2008","unstructured":"Dismuke WM, Mbadugha CC, Ellis DZ. NO-induced regulation of human trabecular meshwork cell volume and aqueous humor outflow facility involve the BKCa ion channel. Am J Physiol Cell Physiol. 2008;294(6):C1378-86. https:\/\/doi.org\/10.1152\/ajpcell.00363.2007.","journal-title":"Am J Physiol Cell Physiol"},{"issue":"11","key":"3620_CR130","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1007\/s00417-002-0559-7","volume":"240","author":"A Schneemann","year":"2002","unstructured":"Schneemann A, Dijkstra BG, van den Berg TJ, Kamphuis W, Hoyng PF. Nitric oxide\/guanylate cyclase pathways and flow in anterior segment perfusion. Graefes Arch Clin Exp Ophthalmol. 2002;240(11):936\u201341. https:\/\/doi.org\/10.1007\/s00417-002-0559-7.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"2","key":"3620_CR131","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s40123-017-0094-6","volume":"6","author":"J Aliancy","year":"2017","unstructured":"Aliancy J, Stamer WD, Wirostko B. A review of nitric oxide for the treatment of glaucomatous disease. Ophthalmol Ther. 2017;6(2):221\u201332. https:\/\/doi.org\/10.1007\/s40123-017-0094-6.","journal-title":"Ophthalmol Ther"},{"issue":"8","key":"3620_CR132","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1016\/s1567-5769(01)00090-x","volume":"1","author":"LR Brunet","year":"2001","unstructured":"Brunet LR. Nitric oxide in parasitic infections. Int Immunopharmacol. 2001;1(8):1457\u201367. https:\/\/doi.org\/10.1016\/s1567-5769(01)00090-x.","journal-title":"Int Immunopharmacol"},{"key":"3620_CR133","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/s1054-3589(08)61095-9","volume":"34","author":"VL Dawson","year":"1995","unstructured":"Dawson VL, Dawson TM. Physiological and toxicological actions of nitric oxide in the central nervous system. Adv Pharmacol. 1995;34:323\u201342. https:\/\/doi.org\/10.1016\/s1054-3589(08)61095-9.","journal-title":"Adv Pharmacol"},{"issue":"8","key":"3620_CR134","doi-asserted-by":"publisher","first-page":"3148","DOI":"10.1128\/iai.64.8.3148-3153.1996","volume":"64","author":"YS Kim","year":"1996","unstructured":"Kim YS, Tauber MG. Neurotoxicity of glia activated by gram-positive bacterial products depends on nitric oxide production. Infect Immun. 1996;64(8):3148\u201353. https:\/\/doi.org\/10.1128\/iai.64.8.3148-3153.1996.","journal-title":"Infect Immun"},{"issue":"1","key":"3620_CR135","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-024-03526-2","volume":"24","author":"J Song","year":"2024","unstructured":"Song J, Dong H, Wang T, Yu H, Yu J, Ma S, et al. What is the impact of microbiota on dry eye: a literature review of the gut-eye axis. BMC Ophthalmol. 2024;24(1):262. https:\/\/doi.org\/10.1186\/s12886-024-03526-2.","journal-title":"BMC Ophthalmol"},{"key":"3620_CR136","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.jtos.2020.09.003","volume":"19","author":"J Andersson","year":"2021","unstructured":"Andersson J, Vogt JK, Dalgaard MD, Pedersen O, Holmgaard K, Heegaard S. Ocular surface microbiota in patients with aqueous tear-deficient dry eye. Ocul Surf. 2021;19:210\u20137. https:\/\/doi.org\/10.1016\/j.jtos.2020.09.003.","journal-title":"Ocul Surf"},{"key":"3620_CR137","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.731867","volume":"9","author":"Q Liang","year":"2021","unstructured":"Liang Q, Li J, Zou Y, Hu X, Deng X, Zou B, et al. Metagenomic analysis reveals the heterogeneity of conjunctival microbiota dysbiosis in dry eye disease. Front Cell Dev Biol. 2021;9:731867. https:\/\/doi.org\/10.3389\/fcell.2021.731867.","journal-title":"Front Cell Dev Biol"},{"issue":"11","key":"3620_CR138","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1007\/s12275-019-9127-2","volume":"57","author":"Z Li","year":"2019","unstructured":"Li Z, Gong Y, Chen S, Li S, Zhang Y, Zhong H, et al. Comparative portrayal of ocular surface microbe with and without dry eye. J Microbiol. 2019;57(11):1025\u201332. https:\/\/doi.org\/10.1007\/s12275-019-9127-2.","journal-title":"J Microbiol"},{"issue":"14","key":"3620_CR139","doi-asserted-by":"publisher","first-page":"4774","DOI":"10.1167\/iovs.19-27719","volume":"60","author":"X Dong","year":"2019","unstructured":"Dong X, Wang Y, Wang W, Lin P, Huang Y. Composition and diversity of bacterial community on the ocular surface of patients with Meibomian gland dysfunction. Investig Ophthalmol Vis Sci. 2019;60(14):4774\u201383. https:\/\/doi.org\/10.1167\/iovs.19-27719.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"3620_CR140","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.2147\/IDR.S162135","volume":"11","author":"X Jiang","year":"2018","unstructured":"Jiang X, Deng A, Yang J, Bai H, Yang Z, Wu J, et al. Pathogens in the Meibomian gland and conjunctival sac: microbiome of normal subjects and patients with Meibomian gland dysfunction. Infect Drug Resist. 2018;11:1729\u201340. https:\/\/doi.org\/10.2147\/IDR.S162135.","journal-title":"Infect Drug Resist"},{"key":"3620_CR141","doi-asserted-by":"publisher","DOI":"10.1128\/microbiolspec.GPP3-0039-2018","author":"K Tam","year":"2019","unstructured":"Tam K, Torres VJ. Staphylococcus aureus secreted toxins and extracellular enzymes. Microbiol Spectr. 2019. https:\/\/doi.org\/10.1128\/microbiolspec.GPP3-0039-2018.","journal-title":"Microbiol Spectr"},{"key":"3620_CR142","first-page":"37","volume":"318","author":"MM Kriet","year":"2011","unstructured":"Kriet MM, Bouya Y, Louaya S. [Endogenous postpartum panophthalmitis induced by Sphingomonas paucimobili]. Bull Soc Belge Ophtalmol. 2011;318:37\u201340.","journal-title":"Bull Soc Belge Ophtalmol"},{"key":"3620_CR143","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.716867","volume":"11","author":"Y Qi","year":"2021","unstructured":"Qi Y, Wan Y, Li T, Zhang M, Song Y, Hu Y, et al. Comparison of the ocular microbiomes of dry eye patients with and without autoimmune disease. Front Cell Infect Microbiol. 2021;11:716867. https:\/\/doi.org\/10.3389\/fcimb.2021.716867.","journal-title":"Front Cell Infect Microbiol"},{"issue":"13","key":"3620_CR144","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.63.13.20","volume":"63","author":"Z Chen","year":"2022","unstructured":"Chen Z, Jia Y, Xiao Y, Lin Q, Qian Y, Xiang Z, et al. Microbiological characteristics of ocular surface associated with dry eye in children and adolescents with diabetes mellitus. Investig Ophthalmol Vis Sci. 2022;63(13):20. https:\/\/doi.org\/10.1167\/iovs.63.13.20.","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"12","key":"3620_CR145","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.62.12.13","volume":"62","author":"Z Zhang","year":"2021","unstructured":"Zhang Z, Zou X, Xue W, Zhang P, Wang S, Zou H. Ocular surface microbiota in diabetic patients with dry eye disease. Investig Ophthalmol Vis Sci. 2021;62(12):13. https:\/\/doi.org\/10.1167\/iovs.62.12.13.","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"7","key":"3620_CR146","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1080\/09273948.2025.2450472","volume":"33","author":"A Sriranganathan","year":"2025","unstructured":"Sriranganathan A, Mihalache A, Grad J, Miranda RN, Felfeli T. Economic burden and cost-effectiveness of management of non-infectious uveitis: a systematic review. Ocul Immunol Inflamm. 2025;33(7):1206\u201326. https:\/\/doi.org\/10.1080\/09273948.2025.2450472.","journal-title":"Ocul Immunol Inflamm"},{"key":"3620_CR147","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13092089","author":"YJ Lee","year":"2025","unstructured":"Lee YJ, Ahn SM, Hong S, Oh JS, Lee CK, Yoo B, et al. Association between adalimumab dosing interval and uveitis recurrence in patients with ankylosing spondylitis. Biomedicines. 2025. https:\/\/doi.org\/10.3390\/biomedicines13092089.","journal-title":"Biomedicines"},{"issue":"10","key":"3620_CR148","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1080\/17474124.2025.2550518","volume":"19","author":"C Vigano","year":"2025","unstructured":"Vigano C, Laffusa A, Pirola L, Cristoferi L, Zuin G, Sansotta N, et al. Extra-intestinal manifestations in inflammatory bowel disease: a comparative review of pediatric and adult-onset disease. Expert Rev Gastroenterol Hepatol. 2025;19(10):1133\u201347. https:\/\/doi.org\/10.1080\/17474124.2025.2550518.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"4","key":"3620_CR149","doi-asserted-by":"publisher","first-page":"419","DOI":"10.4103\/joco.joco_147_24","volume":"36","author":"K Katoch","year":"2024","unstructured":"Katoch K, Sharma RK, Mahajan VK, Tuli R. Ophthalmic comorbidities in patients with chronic plaque psoriasis: a hospital-based cross-sectional study of 100 patients. J Curr Ophthalmol. 2024;36(4):419\u201327. https:\/\/doi.org\/10.4103\/joco.joco_147_24.","journal-title":"J Curr Ophthalmol"},{"issue":"10","key":"3620_CR150","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.93898","volume":"17","author":"KI Llerenas-Aguirre","year":"2025","unstructured":"Llerenas-Aguirre KI, Taboada Moreno B, Orozco Gomez LP. Clinical and ophthalmological characteristics and therapeutic management of patients with sarcoidosis. Cureus. 2025;17(10):e93898. https:\/\/doi.org\/10.7759\/cureus.93898.","journal-title":"Cureus"},{"issue":"1","key":"3620_CR151","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-025-04334-y","volume":"25","author":"F Bezci Aygun","year":"2025","unstructured":"Bezci Aygun F, Akgoz Koyuncuoglu M, Kadayifcilar S, Ozen S. Clinical characteristics and long-term outcomes of Vogt-Koyanagi-Harada disease in pediatric age group. BMC Ophthalmol. 2025;25(1):509. https:\/\/doi.org\/10.1186\/s12886-025-04334-y.","journal-title":"BMC Ophthalmol"},{"issue":"10","key":"3620_CR152","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.55563\/clinexprheumatol\/3dhh59","volume":"43","author":"S Chadli","year":"2025","unstructured":"Chadli S, Maamar M, Abouqal R, Ammouri W, Tazi Mezalek Z, Harmouche H. Identification of clinical phenotypes in Behcet\u2019s syndrome using latent class analysis: a step toward precision medicine. Clin Exp Rheumatol. 2025;43(10):1789\u201398. https:\/\/doi.org\/10.55563\/clinexprheumatol\/3dhh59.","journal-title":"Clin Exp Rheumatol"},{"issue":"9","key":"3620_CR153","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/j.autrev.2014.05.003","volume":"13","author":"PH Papotto","year":"2014","unstructured":"Papotto PH, Marengo EB, Sardinha LR, Goldberg AC, Rizzo LV. Immunotherapeutic strategies in autoimmune uveitis. Autoimmun Rev. 2014;13(9):909\u201316. https:\/\/doi.org\/10.1016\/j.autrev.2014.05.003.","journal-title":"Autoimmun Rev"},{"issue":"11","key":"3620_CR154","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1016\/j.ajpath.2023.03.004","volume":"193","author":"TM Janetos","year":"2023","unstructured":"Janetos TM, Zakaria N, Goldstein DA. The microbiome and uveitis: a narrative review. Am J Pathol. 2023;193(11):1638\u201347. https:\/\/doi.org\/10.1016\/j.ajpath.2023.03.004.","journal-title":"Am J Pathol"},{"issue":"3","key":"3620_CR155","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1159\/000519457","volume":"65","author":"P Donabedian","year":"2022","unstructured":"Donabedian P, Dawson E, Li Q, Chen J. Gut microbes and eye disease. Ophthalmic Res. 2022;65(3):245\u201353. https:\/\/doi.org\/10.1159\/000519457.","journal-title":"Ophthalmic Res"},{"issue":"39","key":"3620_CR156","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000039866","volume":"103","author":"Y Zhao","year":"2024","unstructured":"Zhao Y, Qiu P, Shen T. Gut microbiota and eye diseases: a review. Medicine (Baltimore). 2024;103(39):e39866. https:\/\/doi.org\/10.1097\/MD.0000000000039866.","journal-title":"Medicine (Baltimore)"},{"issue":"12","key":"3620_CR157","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1038\/s41584-018-0097-2","volume":"14","author":"JT Rosenbaum","year":"2018","unstructured":"Rosenbaum JT, Asquith M. The microbiome and HLA-B27-associated acute anterior uveitis. Nat Rev Rheumatol. 2018;14(12):704\u201313. https:\/\/doi.org\/10.1038\/s41584-018-0097-2.","journal-title":"Nat Rev Rheumatol"},{"issue":"6","key":"3620_CR158","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2020.101500","volume":"33","author":"S Kodati","year":"2019","unstructured":"Kodati S, Sen HN. Uveitis and the gut microbiota. Best Pract Res Clin Rheumatol. 2019;33(6):101500. https:\/\/doi.org\/10.1016\/j.berh.2020.101500.","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"1","key":"3620_CR159","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-12163-3","volume":"7","author":"YK Nakamura","year":"2017","unstructured":"Nakamura YK, Janowitz C, Metea C, Asquith M, Karstens L, Rosenbaum JT, et al. Short chain fatty acids ameliorate immune-mediated uveitis partially by altering migration of lymphocytes from the intestine. Sci Rep. 2017;7(1):11745. https:\/\/doi.org\/10.1038\/s41598-017-12163-3.","journal-title":"Sci Rep"},{"issue":"1","key":"3620_CR160","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1167\/iovs.18-24813","volume":"60","author":"C Janowitz","year":"2019","unstructured":"Janowitz C, Nakamura YK, Metea C, Gligor A, Yu W, Karstens L, et al. Disruption of intestinal homeostasis and intestinal microbiota during experimental autoimmune uveitis. Investig Ophthalmol Vis Sci. 2019;60(1):420\u20139. https:\/\/doi.org\/10.1167\/iovs.18-24813.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"3620_CR161","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms13020271","author":"PD Samalia","year":"2025","unstructured":"Samalia PD, Solanki J, Kam J, Angelo L, Niederer RL. From dysbiosis to disease: the microbiome\u2019s influence on uveitis pathogenesis. Microorganisms. 2025. https:\/\/doi.org\/10.3390\/microorganisms13020271.","journal-title":"Microorganisms"},{"key":"3620_CR162","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1614304","volume":"16","author":"M Liu","year":"2025","unstructured":"Liu M, Geng J, Liu T, Liu X. Gut microbiome dysregulation in noninfectious uveitis. Front Immunol. 2025;16:1614304. https:\/\/doi.org\/10.3389\/fimmu.2025.1614304.","journal-title":"Front Immunol"},{"issue":"2","key":"3620_CR163","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1080\/08164622.2024.2422479","volume":"108","author":"S Berzack","year":"2025","unstructured":"Berzack S, Galor A. Microbiome-based therapeutics for ocular diseases. Clin Exp Optom. 2025;108(2):115\u201322. https:\/\/doi.org\/10.1080\/08164622.2024.2422479.","journal-title":"Clin Exp Optom"},{"issue":"14","key":"3620_CR164","doi-asserted-by":"publisher","first-page":"2877","DOI":"10.1038\/s41433-023-02462-7","volume":"37","author":"MW Russell","year":"2023","unstructured":"Russell MW, Muste JC, Kuo BL, Wu AK, Singh RP. Clinical trials targeting the gut-microbiome to effect ocular health: a systematic review. Eye (Lond). 2023;37(14):2877\u201385. https:\/\/doi.org\/10.1038\/s41433-023-02462-7.","journal-title":"Eye (Lond)"},{"key":"3620_CR165","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.1069325","volume":"14","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Wang T, Wan Z, Bai J, Xue Y, Dai R, et al. Alterations of the intestinal microbiota in age-related macular degeneration. Front Microbiol. 2023;14:1069325. https:\/\/doi.org\/10.3389\/fmicb.2023.1069325.","journal-title":"Front Microbiol"},{"issue":"11","key":"3620_CR166","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1016\/j.ajpath.2023.04.006","volume":"193","author":"J Xiao","year":"2023","unstructured":"Xiao J, Zhang JY, Luo W, He PC, Skondra D. The emerging role of gut microbiota in age-related macular degeneration. Am J Pathol. 2023;193(11):1627\u201337. https:\/\/doi.org\/10.1016\/j.ajpath.2023.04.006.","journal-title":"Am J Pathol"},{"issue":"1","key":"3620_CR167","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19490976.2020.1788899","volume":"12","author":"F Dong","year":"2020","unstructured":"Dong F, Hao F, Murray IA, Smith PB, Koo I, Tindall AM, et al. Intestinal microbiota-derived tryptophan metabolites are predictive of Ah receptor activity. Gut Microbes. 2020;12(1):1\u201324. https:\/\/doi.org\/10.1080\/19490976.2020.1788899.","journal-title":"Gut Microbes"},{"issue":"2","key":"3620_CR168","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-05616-3","volume":"14","author":"Y Yang","year":"2023","unstructured":"Yang Y, Wang N, Xu L, Liu Y, Huang L, Gu M, et al. Aryl hydrocarbon receptor dependent anti-inflammation and neuroprotective effects of tryptophan metabolites on retinal ischemia\/reperfusion injury. Cell Death Dis. 2023;14(2):92. https:\/\/doi.org\/10.1038\/s41419-023-05616-3.","journal-title":"Cell Death Dis"},{"key":"3620_CR169","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.117.006347","author":"ML Chen","year":"2017","unstructured":"Chen ML, Zhu XH, Ran L, Lang HD, Yi L, Mi MT. Trimethylamine-N-Oxide induces vascular inflammation by activating the NLRP3 inflammasome through the SIRT3-SOD2-mtROS signaling pathway. J Am Heart Assoc. 2017. https:\/\/doi.org\/10.1161\/JAHA.117.006347.","journal-title":"J Am Heart Assoc"},{"key":"3620_CR170","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.158183","author":"F Saaoud","year":"2023","unstructured":"Saaoud F, Liu L, Xu K, Cueto R, Shao Y, Lu Y, et al. Aorta- and liver-generated TMAO enhances trained immunity for increased inflammation via ER stress\/mitochondrial ROS\/glycolysis pathways. JCI Insight. 2023. https:\/\/doi.org\/10.1172\/jci.insight.158183.","journal-title":"JCI Insight"},{"issue":"3","key":"3620_CR171","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.ophtha.2018.08.006","volume":"126","author":"BMJ Merle","year":"2019","unstructured":"Merle BMJ, Colijn JM, Cougnard-Gregoire A, de Koning-Backus APM, Delyfer MN, Kiefte-de Jong JC, et al. Mediterranean diet and incidence of advanced age-related macular degeneration: the EYE-RISK consortium. Ophthalmology. 2019;126(3):381\u201390. https:\/\/doi.org\/10.1016\/j.ophtha.2018.08.006.","journal-title":"Ophthalmology"},{"key":"3620_CR172","doi-asserted-by":"publisher","DOI":"10.3390\/nu15092043","author":"Y Wu","year":"2023","unstructured":"Wu Y, Xie Y, Yuan Y, Xiong R, Hu Y, Ning K, et al. The Mediterranean diet and age-related eye diseases: a systematic review. Nutrients. 2023. https:\/\/doi.org\/10.3390\/nu15092043.","journal-title":"Nutrients"},{"issue":"12","key":"3620_CR173","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.64.12.32","volume":"64","author":"D Mao","year":"2023","unstructured":"Mao D, Tao B, Sheng S, Jin H, Chen W, Gao H, et al. Causal effects of gut microbiota on age-related macular degeneration: a Mendelian randomization study. Investig Ophthalmol Vis Sci. 2023;64(12):32. https:\/\/doi.org\/10.1167\/iovs.64.12.32.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"3620_CR174","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13030639","author":"P Wei","year":"2025","unstructured":"Wei P, Gao S, Han G. Evidence for genetic causal association between the gut microbiome, derived metabolites, and age-related macular degeneration: a mediation Mendelian randomization analysis. Biomedicines. 2025. https:\/\/doi.org\/10.3390\/biomedicines13030639.","journal-title":"Biomedicines"},{"issue":"8","key":"3620_CR175","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1001\/jamaophthalmol.2023.2289","volume":"141","author":"EA Lundeen","year":"2023","unstructured":"Lundeen EA, Burke-Conte Z, Rein DB, Wittenborn JS, Saaddine J, Lee AY, et al. Prevalence of diabetic retinopathy in the US in 2021. JAMA Ophthalmol. 2023;141(8):747\u201354. https:\/\/doi.org\/10.1001\/jamaophthalmol.2023.2289.","journal-title":"JAMA Ophthalmol"},{"key":"3620_CR176","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1604315","volume":"16","author":"L Xie","year":"2025","unstructured":"Xie L, Lin W. The role of gut microbiota dysbiosis in the inflammatory pathogenesis of diabetic retinopathy. Front Immunol. 2025;16:1604315. https:\/\/doi.org\/10.3389\/fimmu.2025.1604315.","journal-title":"Front Immunol"},{"issue":"11","key":"3620_CR177","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1016\/j.ophtha.2021.04.027","volume":"128","author":"ZL Teo","year":"2021","unstructured":"Teo ZL, Tham YC, Yu M, Chee ML, Rim TH, Cheung N, et al. Global prevalence of diabetic retinopathy and projection of burden through 2045: systematic review and meta-analysis. Ophthalmology. 2021;128(11):1580\u201391. https:\/\/doi.org\/10.1016\/j.ophtha.2021.04.027.","journal-title":"Ophthalmology"},{"issue":"3","key":"3620_CR178","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.109145","volume":"27","author":"S Ben","year":"2024","unstructured":"Ben S, Ma Y, Bai Y, Zhang Q, Zhao Y, Xia J, et al. Microglia-endothelial cross-talk regulates diabetes-induced retinal vascular dysfunction through remodeling inflammatory microenvironment. iScience. 2024;27(3):109145. https:\/\/doi.org\/10.1016\/j.isci.2024.109145.","journal-title":"iScience"},{"key":"3620_CR179","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2020.101799","volume":"37","author":"Q Kang","year":"2020","unstructured":"Kang Q, Yang C. Oxidative stress and diabetic retinopathy: molecular mechanisms, pathogenetic role and therapeutic implications. Redox Biol. 2020;37:101799. https:\/\/doi.org\/10.1016\/j.redox.2020.101799.","journal-title":"Redox Biol"},{"issue":"1","key":"3620_CR180","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-017-0572-6","volume":"17","author":"H Chen","year":"2017","unstructured":"Chen H, Zhang X, Liao N, Wen F. Assessment of biomarkers using multiplex assays in aqueous humor of patients with diabetic retinopathy. BMC Ophthalmol. 2017;17(1):176. https:\/\/doi.org\/10.1186\/s12886-017-0572-6.","journal-title":"BMC Ophthalmol"},{"key":"3620_CR181","doi-asserted-by":"publisher","DOI":"10.3390\/cells12020300","author":"RA Kowluru","year":"2023","unstructured":"Kowluru RA. Cross talks between oxidative stress, inflammation and epigenetics in diabetic retinopathy. Cells. 2023. https:\/\/doi.org\/10.3390\/cells12020300.","journal-title":"Cells"},{"issue":"7418","key":"3620_CR182","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nature11450","volume":"490","author":"J Qin","year":"2012","unstructured":"Qin J, Li Y, Cai Z, Li S, Zhu J, Zhang F, et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature. 2012;490(7418):55\u201360. https:\/\/doi.org\/10.1038\/nature11450.","journal-title":"Nature"},{"issue":"7","key":"3620_CR183","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1016\/j.bbadis.2018.09.032","volume":"1865","author":"R Fernandes","year":"2019","unstructured":"Fernandes R, Viana SD, Nunes S, Reis F. Diabetic gut microbiota dysbiosis as an inflammaging and immunosenescence condition that fosters progression of retinopathy and nephropathy. Biochim Biophys Acta (BBA) Mol Basis Dis. 2019;1865(7):1876\u201397. https:\/\/doi.org\/10.1016\/j.bbadis.2018.09.032.","journal-title":"Biochim Biophys Acta (BBA) Mol Basis Dis"},{"issue":"6","key":"3620_CR184","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.66.6.23","volume":"66","author":"X Qin","year":"2025","unstructured":"Qin X, Sun J, Xu Y, Lu L, Ma Y, Lou F, et al. Short-chain fatty acids are potential biomarkers of immune regulation in diabetic retinopathy. Investig Ophthalmol Vis Sci. 2025;66(6):23. https:\/\/doi.org\/10.1167\/iovs.66.6.23.","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"1","key":"3620_CR185","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1210\/clinem\/dgad452","volume":"109","author":"L Fernandes Silva","year":"2023","unstructured":"Fernandes Silva L, Hokkanen J, Vangipurapu J, Oravilahti A, Laakso M. Metabolites as risk factors for diabetic retinopathy in patients with type 2 diabetes: a 12-year follow-up study. J Clin Endocrinol Metab. 2023;109(1):100\u20136. https:\/\/doi.org\/10.1210\/clinem\/dgad452.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"3620_CR186","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-82538-0","volume":"11","author":"T Das","year":"2021","unstructured":"Das T, Jayasudha R, Chakravarthy S, Prashanthi GS, Bhargava A, Tyagi M, et al. Alterations in the gut bacterial microbiome in people with type 2 diabetes mellitus and diabetic retinopathy. Sci Rep. 2021;11(1):2738. https:\/\/doi.org\/10.1038\/s41598-021-82538-0.","journal-title":"Sci Rep"},{"key":"3620_CR187","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.926926","volume":"13","author":"J Bai","year":"2022","unstructured":"Bai J, Wan Z, Zhang Y, Wang T, Xue Y, Peng Q. Composition and diversity of gut microbiota in diabetic retinopathy. Front Microbiol. 2022;13:926926. https:\/\/doi.org\/10.3389\/fmicb.2022.926926.","journal-title":"Front Microbiol"},{"key":"3620_CR188","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.732204","volume":"9","author":"Z Zhou","year":"2021","unstructured":"Zhou Z, Zheng Z, Xiong X, Chen X, Peng J, Yao H, et al. Gut microbiota composition and fecal metabolic profiling in patients with diabetic retinopathy. Front Cell Dev Biol. 2021;9:732204. https:\/\/doi.org\/10.3389\/fcell.2021.732204.","journal-title":"Front Cell Dev Biol"},{"key":"3620_CR189","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.943325","volume":"13","author":"L Li","year":"2022","unstructured":"Li L, Yang K, Li C, Zhang H, Yu H, Chen K, et al. Metagenomic shotgun sequencing and metabolomic profiling identify specific human gut microbiota associated with diabetic retinopathy in patients with type 2 diabetes. Front Immunol. 2022;13:943325. https:\/\/doi.org\/10.3389\/fimmu.2022.943325.","journal-title":"Front Immunol"},{"issue":"1","key":"3620_CR190","doi-asserted-by":"publisher","DOI":"10.1007\/s00253-024-13316-x","volume":"108","author":"X Qin","year":"2024","unstructured":"Qin X, Sun J, Chen S, Xu Y, Lu L, Lu M, et al. Gut microbiota predict retinopathy in patients with diabetes: a longitudinal cohort study. Appl Microbiol Biotechnol. 2024;108(1):497. https:\/\/doi.org\/10.1007\/s00253-024-13316-x.","journal-title":"Appl Microbiol Biotechnol"},{"issue":"1","key":"3620_CR191","doi-asserted-by":"publisher","DOI":"10.1186\/s13098-025-01813-6","volume":"17","author":"Y Zhou","year":"2025","unstructured":"Zhou Y, Dong J, Wang Z, Huang C, Yu X, Wang X, et al. From background diabetic retinopathy to its proliferative stage. What is the role of gut microbiota in the trajectory of DR? A Mendelian randomization study with mediation analysis. Diabetol Metab Syndr. 2025;17(1):346. https:\/\/doi.org\/10.1186\/s13098-025-01813-6.","journal-title":"Diabetol Metab Syndr"},{"key":"3620_CR192","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.667632","volume":"12","author":"P Ye","year":"2021","unstructured":"Ye P, Zhang X, Xu Y, Xu J, Song X, Yao K. Alterations of the gut microbiome and metabolome in patients with proliferative diabetic retinopathy. Front Microbiol. 2021;12:667632. https:\/\/doi.org\/10.3389\/fmicb.2021.667632.","journal-title":"Front Microbiol"},{"issue":"12","key":"3620_CR193","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0243077","volume":"15","author":"R Jayasudha","year":"2020","unstructured":"Jayasudha R, Das T, Kalyana Chakravarthy S, Sai Prashanthi G, Bhargava A, Tyagi M, et al. Gut mycobiomes are altered in people with type 2 diabetes mellitus and diabetic retinopathy. PLoS ONE. 2020;15(12):e0243077. https:\/\/doi.org\/10.1371\/journal.pone.0243077.","journal-title":"PLoS ONE"},{"key":"3620_CR194","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2024.106590","volume":"189","author":"S Zhao","year":"2024","unstructured":"Zhao S, Yan Q, Xu W, Zhang J. Gut microbiome in diabetic retinopathy: a systematic review and meta-analysis. Microb Pathog. 2024;189:106590. https:\/\/doi.org\/10.1016\/j.micpath.2024.106590.","journal-title":"Microb Pathog"},{"issue":"7","key":"3620_CR195","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.62.7.19","volume":"62","author":"R Khan","year":"2021","unstructured":"Khan R, Sharma A, Ravikumar R, Parekh A, Srinivasan R, George RJ, et al. Association between gut microbial abundance and sight-threatening diabetic retinopathy. Investig Ophthalmol Vis Sci. 2021;62(7):19. https:\/\/doi.org\/10.1167\/iovs.62.7.19.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"3620_CR196","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.646348","volume":"11","author":"Y Huang","year":"2021","unstructured":"Huang Y, Wang Z, Ma H, Ji S, Chen Z, Cui Z, et al. Dysbiosis and implication of the gut microbiota in diabetic retinopathy. Front Cell Infect Microbiol. 2021;11:646348. https:\/\/doi.org\/10.3389\/fcimb.2021.646348.","journal-title":"Front Cell Infect Microbiol"},{"key":"3620_CR197","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.omtm.2019.06.007","volume":"14","author":"A Verma","year":"2019","unstructured":"Verma A, Xu K, Du T, Zhu P, Liang Z, Liao S, et al. Expression of human ACE2 in Lactobacillus and beneficial effects in diabetic retinopathy in mice. Mol Ther Methods Clin Dev. 2019;14:161\u201370. https:\/\/doi.org\/10.1016\/j.omtm.2019.06.007.","journal-title":"Mol Ther Methods Clin Dev"},{"key":"3620_CR198","doi-asserted-by":"publisher","DOI":"10.2337\/db18-33-LB","author":"Q Li","year":"2018","unstructured":"Li Q, Xu K, Du TAO, Zhu P, Verma A. Recombinant probiotics expressing Angiotensin-(1-7) improves glucose metabolism and diabetes-induced renal and retinal injury. Diabetes. 2018. https:\/\/doi.org\/10.2337\/db18-33-LB.","journal-title":"Diabetes"},{"issue":"9","key":"3620_CR199","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.2337\/db18-0158","volume":"67","author":"E Beli","year":"2018","unstructured":"Beli E, Yan Y, Moldovan L, Vieira CP, Gao R, Duan Y, et al. Restructuring of the gut microbiome by intermittent fasting prevents retinopathy and prolongs survival in db\/db mice. Diabetes. 2018;67(9):1867\u201379. https:\/\/doi.org\/10.2337\/db18-0158.","journal-title":"Diabetes"},{"issue":"1","key":"3620_CR200","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1007\/s40200-024-01399-2","volume":"23","author":"H Farajipour","year":"2024","unstructured":"Farajipour H, Matin HR, Asemi Z, Sadr S, Tajabadi-Ebrahimi M, Sharifi N, et al. The effects of probiotics supplements on metabolic indices and clinical signs in patients with diabetic retinopathy, a randomized double blind clinical trial. J Diabetes Metab Disord. 2024;23(1):1133\u201340. https:\/\/doi.org\/10.1007\/s40200-024-01399-2.","journal-title":"J Diabetes Metab Disord"},{"issue":"1","key":"3620_CR201","doi-asserted-by":"publisher","DOI":"10.1186\/s13098-025-01929-9","volume":"17","author":"Y Zeng","year":"2025","unstructured":"Zeng Y, Gao M, Tan X, Wu H, Xiang J, Liu A, et al. The gut-retina axis: association of dietary index for gut microbiota with diabetic retinopathy in diabetic patients-a cross-sectional study from NHANES 2009-2018. Diabetol Metab Syndr. 2025;17(1):359. https:\/\/doi.org\/10.1186\/s13098-025-01929-9.","journal-title":"Diabetol Metab Syndr"},{"key":"3620_CR202","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2023.103038","volume":"141","author":"R Yang","year":"2023","unstructured":"Yang R, Chen Z, Cai J. Fecal microbiota transplantation: emerging applications in autoimmune diseases. J Autoimmun. 2023;141:103038. https:\/\/doi.org\/10.1016\/j.jaut.2023.103038.","journal-title":"J Autoimmun"},{"key":"3620_CR203","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.114816","volume":"163","author":"S Aghamohammad","year":"2023","unstructured":"Aghamohammad S, Hafezi A, Rohani M. Probiotics as functional foods: how probiotics can alleviate the symptoms of neurological disabilities. Biomed Pharmacother. 2023;163:114816. https:\/\/doi.org\/10.1016\/j.biopha.2023.114816.","journal-title":"Biomed Pharmacother"},{"key":"3620_CR204","doi-asserted-by":"publisher","DOI":"10.3390\/nu13093211","author":"HY Li","year":"2021","unstructured":"Li HY, Zhou DD, Gan RY, Huang SY, Zhao CN, Shang A, et al. Effects and mechanisms of probiotics, prebiotics, synbiotics, and postbiotics on metabolic diseases targeting gut microbiota: a narrative review. Nutrients. 2021. https:\/\/doi.org\/10.3390\/nu13093211.","journal-title":"Nutrients"},{"key":"3620_CR205","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11041016","author":"A Boicean","year":"2023","unstructured":"Boicean A, Birlutiu V, Ichim C, Anderco P, Birsan S. Fecal microbiota transplantation in inflammatory bowel disease. Biomedicines. 2023. https:\/\/doi.org\/10.3390\/biomedicines11041016.","journal-title":"Biomedicines"},{"issue":"2","key":"3620_CR206","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/s41433-021-01668-x","volume":"36","author":"MH Goldstein","year":"2022","unstructured":"Goldstein MH, Silva FQ, Blender N, Tran T, Vantipalli S. Ocular benzalkonium chloride exposure: problems and solutions. Eye (Lond). 2022;36(2):361\u20138. https:\/\/doi.org\/10.1038\/s41433-021-01668-x.","journal-title":"Eye (Lond)"},{"issue":"9","key":"3620_CR207","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.63.9.32","volume":"63","author":"CJ Chang","year":"2022","unstructured":"Chang CJ, Somohano K, Zemsky C, Uhlemann AC, Liebmann J, Cioffi GA, et al. Topical glaucoma therapy is associated with alterations of the ocular surface microbiome. Investig Ophthalmol Vis Sci. 2022;63(9):32. https:\/\/doi.org\/10.1167\/iovs.63.9.32.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"3620_CR208","doi-asserted-by":"publisher","first-page":"191","DOI":"10.2147\/IDR.S24250","volume":"4","author":"R Honda","year":"2011","unstructured":"Honda R, Toshida H, Suto C, Fujimaki T, Kimura T, Ohta T, et al. Effect of long-term treatment with eyedrops for glaucoma on conjunctival bacterial flora. Infect Drug Resist. 2011;4:191\u20136. https:\/\/doi.org\/10.2147\/IDR.S24250.","journal-title":"Infect Drug Resist"},{"key":"3620_CR209","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2025.110734","volume":"262","author":"D Borroni","year":"2026","unstructured":"Borroni D, Lo Monaco F, Ferraro S, Mazzotta C, Settino M, Gabrielli F, et al. Ocular surface microbiota in primary open angle glaucoma. Exp Eye Res. 2026;262:110734. https:\/\/doi.org\/10.1016\/j.exer.2025.110734.","journal-title":"Exp Eye Res"},{"issue":"8","key":"3620_CR210","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1097\/IJG.0000000000002448","volume":"33","author":"CJ Chang","year":"2024","unstructured":"Chang CJ, Liu B, Liebmann JM, Cioffi GA, Winn BJ. Glaucoma and the human microbiome. J Glaucoma. 2024;33(8):529\u201338. https:\/\/doi.org\/10.1097\/IJG.0000000000002448.","journal-title":"J Glaucoma"},{"issue":"2","key":"3620_CR211","doi-asserted-by":"publisher","DOI":"10.1167\/tvst.12.2.32","volume":"12","author":"A Priluck","year":"2023","unstructured":"Priluck A, Ramulu P, Dosto N, Quigley H, Abraham A. Validation of 16S rRNA gene sequencing of the periocular microbiome and lack of alteration by topical eyedrops. Transl Vis Sci Technol. 2023;12(2):32. https:\/\/doi.org\/10.1167\/tvst.12.2.32.","journal-title":"Transl Vis Sci Technol"},{"issue":"2","key":"3620_CR212","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1365-2567.2010.03301.x","volume":"131","author":"G Weiss","year":"2010","unstructured":"Weiss G, Rasmussen S, Zeuthen LH, Nielsen BN, Jarmer H, Jespersen L, et al. Lactobacillus acidophilus induces virus immune defence genes in murine dendritic cells by a Toll-like receptor-2-dependent mechanism. Immunology. 2010;131(2):268\u201381. https:\/\/doi.org\/10.1111\/j.1365-2567.2010.03301.x.","journal-title":"Immunology"},{"issue":"5","key":"3620_CR213","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1073\/pnas.0904055107","volume":"107","author":"HK Kwon","year":"2010","unstructured":"Kwon HK, Lee CG, So JS, Chae CS, Hwang JS, Sahoo A, et al. Generation of regulatory dendritic cells and CD4+Foxp3+ T cells by probiotics administration suppresses immune disorders. Proc Natl Acad Sci USA. 2010;107(5):2159\u201364. https:\/\/doi.org\/10.1073\/pnas.0904055107.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"3620_CR214","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1002\/ibd.20525","volume":"14","author":"C Vanderpool","year":"2008","unstructured":"Vanderpool C, Yan F, Polk DB. Mechanisms of probiotic action: implications for therapeutic applications in inflammatory bowel diseases. Inflamm Bowel Dis. 2008;14(11):1585\u201396. https:\/\/doi.org\/10.1002\/ibd.20525.","journal-title":"Inflamm Bowel Dis"},{"issue":"6","key":"3620_CR215","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1097\/MOG.0b013e32834baa4d","volume":"27","author":"F Yan","year":"2011","unstructured":"Yan F, Polk DB. Probiotics and immune health. Curr Opin Gastroenterol. 2011;27(6):496\u2013501. https:\/\/doi.org\/10.1097\/MOG.0b013e32834baa4d.","journal-title":"Curr Opin Gastroenterol"},{"issue":"2","key":"3620_CR216","doi-asserted-by":"publisher","first-page":"163","DOI":"10.3920\/BM2020.0101","volume":"12","author":"BI Layus","year":"2021","unstructured":"Layus BI, Gomez MA, Cazorla SI, Rodriguez AV. Drops of Lactiplantibacillus plantarum CRL 759 culture supernatant attenuates eyes inflammation induced by lipopolysaccharide. Benef Microbes. 2021;12(2):163\u201374. https:\/\/doi.org\/10.3920\/BM2020.0101.","journal-title":"Benef Microbes"},{"key":"3620_CR217","doi-asserted-by":"publisher","DOI":"10.3390\/cells10010023","author":"O Dusek","year":"2020","unstructured":"Dusek O, Fajstova A, Klimova A, Svozilkova P, Hrncir T, Kverka M, et al. Severity of experimental autoimmune uveitis is reduced by pretreatment with live probiotic Escherichia coli Nissle 1917. Cells. 2020. https:\/\/doi.org\/10.3390\/cells10010023.","journal-title":"Cells"},{"issue":"14","key":"3620_CR218","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1007\/s10068-023-01378-y","volume":"32","author":"NK Lee","year":"2023","unstructured":"Lee NK, Park YS, Kang DK, Paik HD. Paraprobiotics: definition, manufacturing methods, and functionality. Food Sci Biotechnol. 2023;32(14):1981\u201391. https:\/\/doi.org\/10.1007\/s10068-023-01378-y.","journal-title":"Food Sci Biotechnol"},{"issue":"6","key":"3620_CR219","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1167\/tvst.10.6.8","volume":"10","author":"R Iorio","year":"2021","unstructured":"Iorio R, Petricca S, Luzi C, Bellio P, Cristiano L, Festuccia C, et al. Lactobacillus sakei pro-Bio65 reduces TNF-alpha expression and upregulates GSH content and antioxidant enzymatic activities in human conjunctival cells. Transl Vis Sci Technol. 2021;10(6):8. https:\/\/doi.org\/10.1167\/tvst.10.6.8.","journal-title":"Transl Vis Sci Technol"},{"issue":"9","key":"3620_CR220","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1080\/09273948.2024.2310173","volume":"32","author":"BI Layus","year":"2024","unstructured":"Layus BI, Gomez MA, Cazorla SI, Rodriguez AV. A postbiotic formulation of Lactiplantibacillus plantarum CRL 759 attenuates endotoxin induced uveitis. Ocul Immunol Inflamm. 2024;32(9):1973\u201382. https:\/\/doi.org\/10.1080\/09273948.2024.2310173.","journal-title":"Ocul Immunol Inflamm"},{"issue":"1","key":"3620_CR221","doi-asserted-by":"publisher","first-page":"40","DOI":"10.18240\/ijo.2022.01.06","volume":"15","author":"M Filippelli","year":"2022","unstructured":"Filippelli M, dell\u2019Omo R, Amoruso A, Paiano I, Pane M, Napolitano P, et al. Effectiveness of oral probiotics supplementation in the treatment of adult small chalazion. Int J Ophthalmol. 2022;15(1):40\u20134. https:\/\/doi.org\/10.18240\/ijo.2022.01.06.","journal-title":"Int J Ophthalmol"},{"key":"3620_CR222","doi-asserted-by":"publisher","DOI":"10.12659\/AJCR.931321","volume":"22","author":"P Napolitano","year":"2021","unstructured":"Napolitano P, Filippelli M, D\u2019Andrea L, Carosielli M, dell\u2019Omo R, Costagliola C. Probiotic supplementation improved acute anterior uveitis of 3-year duration: a case report. Am Case Rep. 2021;22:e931321. https:\/\/doi.org\/10.12659\/AJCR.931321.","journal-title":"Am Case Rep"},{"key":"3620_CR223","doi-asserted-by":"publisher","first-page":"548","DOI":"10.12659\/AJCR.912023","volume":"20","author":"G Askari","year":"2019","unstructured":"Askari G, Moravejolahkami AR. Synbiotic supplementation may relieve anterior uveitis, an ocular manifestation in Behcet\u2019s Syndrome. Am J Case Rep. 2019;20:548\u201350. https:\/\/doi.org\/10.12659\/AJCR.912023.","journal-title":"Am J Case Rep"},{"key":"3620_CR224","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11164889","author":"A Tavakoli","year":"2022","unstructured":"Tavakoli A, Markoulli M, Papas E, Flanagan J. The impact of probiotics and prebiotics on dry eye disease signs and symptoms. J Clin Med. 2022. https:\/\/doi.org\/10.3390\/jcm11164889.","journal-title":"J Clin Med"},{"issue":"1","key":"3620_CR225","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-41182-6","volume":"13","author":"J Feng","year":"2023","unstructured":"Feng J, Chen Y, Liu Y, Lin L, Lin X, Gong W, et al. Efficacy and safety of fecal microbiota transplantation in the treatment of ulcerative colitis: a systematic review and meta-analysis. Sci Rep. 2023;13(1):14494. https:\/\/doi.org\/10.1038\/s41598-023-41182-6.","journal-title":"Sci Rep"},{"issue":"6","key":"3620_CR226","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1177\/1756283X12453637","volume":"5","author":"F Rohlke","year":"2012","unstructured":"Rohlke F, Stollman N. Fecal microbiota transplantation in relapsing Clostridium difficile infection. Ther Adv Gastroenterol. 2012;5(6):403\u201320. https:\/\/doi.org\/10.1177\/1756283X12453637.","journal-title":"Ther Adv Gastroenterol"},{"key":"3620_CR227","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.ajo.2021.06.022","volume":"233","author":"A Watane","year":"2022","unstructured":"Watane A, Cavuoto KM, Rojas M, Dermer H, Day JO, Banerjee S, et al. Fecal microbial transplant in individuals with immune-mediated dry eye. Am J Ophthalmol. 2022;233:90\u2013100. https:\/\/doi.org\/10.1016\/j.ajo.2021.06.022.","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"3620_CR228","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1242\/dmm.017400","volume":"8","author":"TL Nguyen","year":"2015","unstructured":"Nguyen TL, Vieira-Silva S, Liston A, Raes J. How informative is the mouse for human gut microbiota research? Dis Model Mech. 2015;8(1):1\u201316. https:\/\/doi.org\/10.1242\/dmm.017400.","journal-title":"Dis Model Mech"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-026-03620-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-026-03620-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-026-03620-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T17:16:39Z","timestamp":1785518199000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-026-03620-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,19]]},"references-count":228,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["3620"],"URL":"https:\/\/doi.org\/10.1007\/s12325-026-03620-5","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,19]]},"assertion":[{"value":"3 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Konstantinos Benekos, Panagiotis Laspas, Konstantinos H. Katsanos, Fotios S. Fousekis, Georgios D. Panos, Charilaos Kostoulas, Ioannis Georgiou, Robert Luca, Beryl Zhou have nothing to disclose; Prof Andreas Katsanos: research funding from Th\u00e9a, fees for consultancy and lectures with travel support from Vianex, Laboratoires Th\u00e9a; congress expenses: Cooper. Iordanis Vagiakis: travel support from Vianex; Prof Dimitra Skondra: consultant\/advisory board with Abbvie, Eyepoint, Biogen, Boehringer, Regeneron; Anastasios G. Konstas: research funding from Bayer, Omni Vision, Santen and Th\u00e9a; fees for consultancy and lectures with travel support from Esteve, Intermed, Santen, Th\u00e9a and Vianex. Anastasios G. Konstas is an Editorial Board member of Advances in Therapy. Anastasios G. Konstas was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions.","order":1,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article is based on previously conducted studies and does not contain any studies with human participants or animals performed by any of the authors.","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}